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ABSTRACT 
 
Accurate measurement of enzyme kinetics is an essential part of understanding the 
mechanisms of biochemical reactions.  The typical means of studying such systems use 
stirred cuvettes, stopped-flow apparatus, microfluidic systems, or other small sample 
containers.  These reaction-kinetics measurements reactors are usually made of quartz, glass, 
or an easily-moldable polymer such as polydimethylsiloxane.  For studying enzyme kinetics 
or free radical chemistry, using small volumes with high concentrations is desirable, but 
interactions of biochemical moieties with these materials can be problematic.  The main 
obstacle is that, as the system volume shrinks, the ratio of surface area to volume increases.  
As a result, the importance of adsorption can increase, and proteins sticking to walls, 
biofilms grow on walls, and radicals annihilating on walls can become significant.  Thus, 
under these circumstances, typical microfluidic systems are incompatible with the demands 
of accurate study of many biochemical systems. 
 
Over the past five years, acoustic levitation has become a technique uniquely suited to 
studying biochemical reactions.  Acoustic levitation offers several advantages over typical 
reaction systems, including small sample volume (and mass), the prevention of chemical 
contamination between drops and external objects, rapid mixing within the drop as a result of 
circulation driven by the levitating ultrasound, and freedom from wall interactions.  We have 
developed an Acoustically-Levitated Drop Reactor (LDR) to study enzyme-catalyzed 
reaction kinetics related to free-radical and oxidative stress chemistry.   
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Microliter-scale droplet generation, reactant introduction, maintenance, and fluid removal are 
all important aspects in conducting reactions in a levitated drop.  Therefore, we developed a 
three-capillary bundle system to address these needs.  Since the capillary system is used to 
introduce drops to the levitation cavity, our LDR system is not 100% wall-less, but the ratio 
of solid surface area to drops surface area is less than 20%, which is low compared to all the 
other reaction systems.  The largest interface seen by reactants is a liquid/gas interface.   
 
Herein, I report kinetic measurements for both luminol chemiluminescence and the reaction 
of pyruvate with nicotinamide adenine dinucleotide, catalyzed by lactate dehydrogenase in a 
levitated drop.  Observations of the chemiluminescence experiment showed second-order 
kinetics were detected within experimental error prior to deviations seen after 10 s.   For the 
enzyme-catalyzed reaction kinetic measurements, it was found that the KM for lactate 
dehydrogenase matched literature values to better than one standard deviation of the 
literature experiment.  Also studied were the effects of laser exposure on the stability of 
Myeloperoxidase at the liquid/gas interface.  It was found that although myeloperoxidase 
degrades over several hours in buffer, there is no indication that the degradation is due to 
either denaturation at the free surface or to two-photon photolysis. 
   
Based on our accomplishments, we demonstrate the feasibility of using a levitated drop as a 
microreactor.  The reactions discussed utilized in-house developed fiber optic and laser-based 
optical detection systems to monitor reaction kinetics inside a levitated drop via 
chemiluminescence and fluorescence.  Outgrowths of these accomplishments will hopefully 
lead to the use of additional detection systems (including electrochemical and mass 
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spectrometry) with the LDR to study a wide variety of biochemical reaction kinetics. 
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CHAPTER 1 
INTRODUCTION, OVERVIEW AND RESEARCH OUTLINE 
1.1 Biochemical Context 
The human body is an extremely complex system that has been studied for hundreds of years, 
yet is still incompletely understood.  One serious problem is that although each individual’s 
body is similar in make-up, there are genetic differences that set each apart and make it 
difficult to rationalize the many variations among individuals.  If one model cannot explain 
how each individual functions, then it is little wonder that one medicine may give quite 
different responses to the same disease in different individuals.  The human body, its 
organization and its many reactions, are worth studying and understanding to make 
preventive care more effective, and to improve drug development.  Systems biology is the 
area of research attacking this issue.  By developing theories and conducting research, the 
idea of personalized health care may become a reality.  It will also change the way 
immunology is studied. 
 
1.2 Systems Biology and Enzyme Kinetics 
Systems biology is a useful tool for studying biological networks such as the human innate 
immune system.  Systems biology is the study of interactions between biological compounds, 
such as enzymes.1  Systems biology is not necessarily focused on the components 
themselves, but the nature of the links that connect them and the functional states of the 
networks as a result of the link’s assembly.2  The interactions between enzymes and small 
molecules are often represented as a connected graph or network.1,3,4  Within the network 
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there are layers of information; each layer increasing in detail.  The first layer of information 
is the statement of the existence of an interaction.  The second, more detailed, layer of a 
network is the approximation of enzymes as a combination of switches that are opened and 
closed in a specific order to describe feed-back, feed-forward, inhibition, and activation 
interactions and mechanisms.  However, the ultimate description of a network contains the 
kinetic information of every enzyme-catalyzed reaction in the network.  This third layer of 
detail allows for the formation of a timeline of events of each species in the network.  In 
order to fully maximize the understanding of an enzyme interaction network, the kinetic 
information of the enzyme-catalyzed reactions must be obtained. 
 
Unfortunately, obtaining kinetic information for every enzyme in a reaction network can be 
difficult.  Reaction kinetics, which are not limited to enzyme-catalyzed reactions, are affected 
by a number of parameters beyond reactant, product, and enzyme concentrations.  The 
conditions of the environment, as well as other species present in the system, must be 
understood and controlled to obtain accurate, reliable, and reproducible kinetics data.  The 
sheer number of parameters and species involved in measuring enzyme-catalyzed reaction 
kinetics as a network of interactions requires the development of novel instrumentation. 
 
Complicating the measurement of kinetics is the difference in environments between in vivo 
and in vitro measurements.  Ideally, all of biology and bioanalytical chemistry would be 
conducted in vivo.  But for many reasons, including but not limited to subject safety, complex 
heterogeneous systems, uncontrolled environment, ambiguous results, and lack of specificity, 
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not all measurements can be made in vivo, so instead model environments are widely used to 
mimic environments seen in nature.   
 
One example is a continuously-stirred reactor (CSTR).  Traditionally, a CSTR is a quartz, 
glass, or polymer vial with injection ports and removal ports, and a stirring mechanism, to 
accurately control the environment.  Unfortunately, such systems prove to be problematic 
when studying enzyme kinetics.  Interactions with the reactor walls cause adsorption of 
reactants and products to the walls can of the vessel.  These wall interactions add an 
additional layer of complexity to the already complex system, changing concentrations and 
adding surface-catalyzed steps to bulk mechanisms.  Developing a reaction system that offers 
all of the benefits of a CSTR, with minimal wall interactions, is critical to studying 
biochemical kinetics. 
  
1.3 Research Summary 
This thesis recaps the five-year journey to the development of a wall-less instrumentation 
system to study enzyme reaction kinetics.  It begins with the specific motivations behind this 
research, the specific biochemical reaction system on which we chose to focus, and reasons 
for choosing the particular system.   
 
We chose to study the peroxidase-oxidase reactions involving the enzyme myeloperoxidase 
(MPO)  (Figure 1.1).  Although understanding the entire immune response system would be 
profitable, it is too large to study in its entirety with existing measurement technology.  
However, with MPOs centrality to the function of neutrophils, we are confident that the 
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system chosen will have a significant impact in immunology research.  We have chosen to 
study MPO because it is arguably one of the most important enzymes involved in fighting 
foreign microorganisms that invade the human body.  This argument is based on the 
enzyme's ability to generate toxic oxidants such as hypochlorite (HOCl), which has been 
thought to be responsible for killing foreign invaders (although the role of MPO is more 
complicated than simply being an HOCl source).4-7  Along with MPOs positive aspects, there 
are also negative ones.  The expression of MPO has been linked to the onset of 
atherosclerosis and several autoimmune diseases such as osteoarthritis and cystic fibrosis.  
Understanding MPO enzyme kinetics can further elucidate its positive and negative effects, 
as well as provide insight on ways to regulate the enzyme expression and activity so that it 
fights foreign invaders but not against the host.  A review of the published literature 
concerning this research can be found in Chapter 2.  
 
Next this thesis discusses briefly the design and, in greater detail, the development and 
employment of an acoustically levitated drop reactor as an instrument for studying enzyme-
catalyzed reactions.  Much of the design of this instrument was discussed in Christopher 
Field’s thesis,8 and is summarized in Chapter 2.  Employment of the levitator system to study 
enzyme kinetics is described in Chapter 3.  The development of the levitator’s sample 
handling system along with proof-of-concept experiments and enzyme kinetics 
measurements are also reported in Chapter 3.  Chapter 4 discusses experiments supportive of 
work on behavior of MPO at the gas-liquid interface.  Chapter 5 suggests next steps for study 
of MPO kinetics and levitator development now that initial steps have succeeded. 
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Throughout this thesis, examples for potential use of a microliter-sized drop as a 
microreactor, to study enzyme catalyzed reactions in a manner similar to a CSTR are 
presented.   Also shown are sample sizes that can be reduced by a factor of 1000 compared to 
macroscale systems.  The most important finding is that enzyme catalyzed reactions 
performed on the microscale, for reactions that do not include free radicals as reactants, 
intermediates, or products, produce results similar to those generated in macroscale systems.  
One thing this research set out to accomplish, but will need to be pursued by the next 
researcher, is to note the differences in the kinetics data between walled- and wall-free 
systems for reactions that do involve free radicals.  The hypothesis is that there will be 
significant differences, primarily in the rate constants, due to the lack of wall interactions.  
Data are presented to support our theories and are discussed in great detail in the following 
chapters.   
 
There are several directions research can go in the light of results reported here.  Projects 
may include further developments on the levitated drop reactor and sample handling systems, 
and experiments that prove a wall-less, microliter-sized drop is useful in studying not only 
MPO but an array of biochemical and enzyme-catalyzed reactions.  In addition, work on 
integrating additional detection systems into the levitator to study other changes (structure, 
activity, pH, side-reactions, etc.) that occur within biochemical reactions would prove useful.  
Understanding the drop dynamics for this particular levitator system will also be important 
for future work.  Detailed suggestions are provided in Chapter 5 on recommended future 
directions.  
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1.5  Chapter 1 Figures 
 
Figure 1.1  Hypothesized Myeloperoxidase Reaction Network. Diagram by A. Scheeline, 
University of Illinois Urbana Champaign. Used with permission. 
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CHAPTER 2 
RESEARCH BACKGROUND 
 
2.1 Immunology: The Innate Immune Response 
One of the most complex biological systems is the immune system.  The immune system is a 
collection of mechanisms that protect against infection by identifying and killing pathogens 
using layered defenses of increasing specificity.1  It detects pathogens and distinguish them 
from the body’s normal cells and tissues.   There are innate and adaptive components to the 
immune system.  The innate subsystem is the first responder.  A pathogen is recognized and 
the innate system responds immediately, but in a generic way.  If a pathogen evades the 
innate response, the adaptive immune response is employed to adapt its response during 
infection to improve its recognition of the pathogen.  The innate immune system is the 
dominant system of host defense.   This thesis focuses entirely on the innate immune 
response and more specifically the roles of neutrophils and macrophages. 
 
The innate immune response is the first line of defense but lacks the ability to recognize or 
remember pathogens, or to provide specific protection against re-infection.  Adaptive 
immunity on the other hand is very specific.  It is based on a clonal selection from a 
repertoire of lymphocytes bearing highly diverse antigen-specific receptors that enable the 
immune system to recognize foreign antigens.2   Both adaptive and innate immunity depend 
on the activities of the white blood cells, or leukocytes.  Innate immunity largely employs 
granulocytes or macrophages while the adaptive immunity relies on lymphocytes.  
Granulocytes, which are also referred to as polymorphonuclear leukocytes, are a diverse 
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collection of white blood cells whose granules provide them with their characteristic staining 
patterns.  
 
In order to protect the host, the innate and adaptive immune systems must work together.  
Most infections are handled successfully by the innate immune system and cause no disease.  
Other infections that cannot be resolved by the innate immunity trigger an adaptive immune 
response.  Because there is a delay of between 4 to 7 days before initial adaptive response 
takes effect, the innate immune response plays a critical role in controlling infections during 
this period.   
 
The cells of the immune system originate in the bone marrow, where they mature.  Once 
mature, the cells migrate to guard the peripheral tissues, circulating in the blood and in 
specialized vessel systems called the lymphatic system.   The myeloid progenitor is the 
precursors of the granulocytes, macrophages, dendritic cells and mast cells specific to the 
innate immune response. Neutrophils, eosinophils, and basophils, are collectively known as 
granulocytes.  Neutrophils, the granulocyte discussed in this remainder of this chapter, are 
short-lived cells that are abundant in the blood.  These phagocytic cells’ key role in the innate 
immunity is to recognize, ingest and destroy pathogens without the aid of the adaptive 
immune response.  
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2.2 Myeloperoxidase: Its Role in Immunology, Reaction Mechanisms 
and Positive/Negative Implications 
 
Of all its host defense mechanisms, the mechanism that involves the enzyme 
myeloperoxidase (MPO) is the most heavily studied and debated concerning its role, impact, 
and reaction network dynamics.3-6 
 
The heme-containing enzyme, MPO, is one of the major players in the first line of non-
specific immune defense system, responsible for the microbial activity within human 
neutrophils (Figure 2.1).7  MPO is the product of a single 11kb gene, composed of 11 introns 
and 12 exons8 located in the long arm of chromosome 17 in segment q12-24.8-12  Mature 
MPO (Figure 2.2)13 is approximately 150 kDa and consists of a pair of heavy-light 
promoters14-16 whose heavy subunits are linked by a disulfide bond along their long axis.14  
MPO is a strongly basic protein with an isoelectric point > 10,17 and therefore binds avidly to 
negatively charged surfaces.  The enzyme is packed inside the cytoplasmic azurophilic 
granules.  The concentration of MPO in the granules is relatively high and accounts for up to 
5% of the dry weight of the cell.18 
 
Upon invasion of the body by a microorganism, neutrophils are first activated, then they 
leave the blood stream and migrate towards the infected site.  Then the process of bacterial 
killing, phagocytosis, takes place after the bacterium is completely surrounded by the 
phagosome, an organelle specialized for this purpose (Figure 2.3).  Once the microbe is 
inside the phagosome, granules containing the biological machinery needed to kill the 
microbe attach themselves to the membrane of the phagosome and dump their machinery 
into the extracellular medium between the phagosome membrane and the microbe. This 
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process is known as degranulation.  During the degranulation process, the concentration of 
MPO within the phagosome equates to roughly 2 mM.19 
 
Within the phagosome (Figure 2.3),20 a bacterium is killed by cytotoxic agents.6  One of 
those toxic agents is hydrogen peroxide (H2O2). The H2O2 required for the MPO-mediated 
antimicrobial system may come from a variety of sources; one being NADPH oxidase.21  
NADPH oxidase is an enzyme complex that assembles in the phagosomal membrane where 
it converts oxygen into the superoxide radical ion (O2-•), then undergoes dismutation to 
produce H2O2.1 MPO exhibits both peroxidase and oxidizing activity, and when released 
inside the phagosome catalyzes several reactions (Figure 2.4A), referred to as the MPO-
mediated antimicrobial system, one being the reaction of hydrogen peroxide (H2O2) with 
chloride (Cl-) to form hypochlorous acid (HOCl), which has antibacterial activity (Figure 2.4 
B).22-24  Figure 2.4 A suggests that MPO-induced killing involves Compound I (CpI) 
catalyzing a variety of compounds into free radicals and forming Compound II (CpII). The 
free radicals produced from this reaction then interact with the engulfed microbe. CpII can 
react with superoxide or additional reducing agents to return to the native state (MP3+) and 
form oxygen or more radicals, respectively. Native MPO (MP3+) can also react with 
superoxide to form Compound III (CpIII or MPO2 in the table of Figure 2.5), but CpIII's 
utility within the phagosome is still in question.25 This simplified reaction network suggest 
that MPO has a direct involvement in the killing function of neutrophils. 
 
It is highly likely that  HOCl is involved in the killing of microorganisms.  As HOCl has a 
pKa of 7.53, it exists as a mixture of the undissociated acid and the hypochlorite ion at 
physiologic pH levels. When the pH is lowered, as may occur in the phagosome, HOCl 
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predominates, and it can react with excess chloride to form molecular chlorine (Cl2).26-28  
These products, which are the reactive components of standard household bleach, are highly 
reactive and thus, short-lived, oxidizing agents that can attack the microorganisms at a 
variety of chemical sites.29  Essentially, any oxidizable group on the organism can be 
oxidized, and as a consequence, there may be a loss of microbial membrane transport,30 an 
interruption of the membrane electron transport chain,31 dissipation of adenylate energy 
reserves,32 and suppression of DNA synthesis with associated disruption of the interaction of 
the microbial cell membrane with the chromosomal origin of replication.33  HOCl also reacts 
with nitrogen-containing compounds to form nitrogen-chlorine derivatives such as 
monochloramines and dichloramines, which can degrade to the corresponding aldehyde.34,35  
Some of these compounds retain oxidizing activity.  For example, taurine, which is present at 
a high concentration in neutrophil cytoplasm,36,37 reacts with HOCl to form taurine 
chloramine, which is less toxic than HOCl, and this reaction has thus been implicated as a 
mechanism by which neutrophils are protected from HOCl released into the cytoplasm.  The 
chloramines are long-lived, thus providing a mechanism for the prolongation of the oxidant 
activity of the peroxidase system.  This allows for the penetration of MPO-derived oxidants 
into complex biological fluids, facilitating transport of toxicity to regions sufficiently distant 
that more reactive products are readily scavenged.  
 
Oscillations in the reactive oxygen species and NADPH concentrations as a result of 
neutrophil activation and migration have been shown.38,39  Any time there is third or higher 
order chemical reaction involving autocatalysis and feedback, oscillatory reactions are 
possible.   Neutrophils exhibit intrinsic sinusoidal metabolite oscillations when both resting 
 13 
and migrating.40  Although the mechanisms for such oscillations have not been resolved, it 
has been proposed that various biochemical oscillators such as glycolysis and cytostolic 
calcium/inositol and calcium/AMP are possible sources of oscillations within cells and that 
myeloperoxidase, independent of exogenous oscillators, may initiate oscillations.38  In order 
to understand neutrophil activation and phagocytosis, it is pertinent to understand the 
oscillatory behavior and how the cellular composition affects these oscillations.   
 
In previous studies, it has been shown that peroxidase-oxidase (PO) reaction (2.1): 
 
2NADH + O2                           2NAD+ + 2 H2O    (2.1) 
 
is activated by melatonin, a substrate found in neutrophils. Such studies have employed 
horseradish peroxidase (HRP) or lactoperoxidase as catalysts, as these are more readily 
obtained than MPO.  In 2003, Petty and co-workers showed that at pHs between 4 and 6, 
melatonin induces oscillations in this reaction.41  Unfortunately the experimental data were 
limited to only one set of conditions (100-125 µM NADH, 200 µM melatonin at a pH of 5.1).  
Olsen et al., in 2004, then proposed a mechanism consistent with Petty's observations and 
obtained transient oscillations using MPO.42 
Enzyme 
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Since MPO is similar to lactoperoxidase and melatonin has been shown to be a substrate for 
the classical peroxidase reaction (2.2), 
 
YH2 + O2                          Y + 2 H2O       (2.2) 
 
which is also catalyzed by MPO, it is suggested that a MPO-catalyzed PO reaction could be 
involved in neutrophil oscillations.  Much of the interest in the peroxidase-oxidase system 
came from the idea that it is a model system for many aspects of nonlinear dynamics in 
biology.  Through modeling of these complex chemical perturbations, along with performing 
experiments to confirm results of simulation, will come increased ability to identify 
important interactions, pathways and compounds that influence biological networks where 
MPO is involved. 
 
MPO is arguably the most important enzyme involved in host defense, due to its ability to 
generate toxic oxidants such as hypochlorous acid (HOCl), which is thought to kill foreign 
invaders.  Unfortunately, the description of MPO’s role in host defense is relatively vague 
considering the complex network in which MPO is involved.  It is clear that although there 
are many things known or that have been studied in reference to the free radical-radical 
reactions involving MPO, there are many more details that are not yet well understood by the 
peroxidase community, which has led to great debate.4, 43-46  
 
Despite its positive role in microbial killing, MPO and it products, have been implicated in a 
number of diseases like atherosclerosis, rheumatoid arthritis, lung cancer, cardiovascular 
Enzyme 
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disease, multiple sclerosis, and Alzheimer’s disease.47-51 While MPO has been implicated in 
the pathologies of these diseases, MPO’s mechanistic involvement is also largely unknown. 
The MPO reaction network is vast, with a large number of reactions that have not been 
extensively studied.  A hypothesized network was shown in Figure 1.1. The vast majority of 
reactions depicted in Figure 1.1 have no experimentally measured kinetic information.43, 45, 52-
70  The kinetics surrounding MPO function inside and out of the phagosome are prime 
candidates for investigation both experimentally (rate constant measurements) and 
theoretically (reaction network simulations).71 Theoretical investigations into the reaction 
network of MPO have recently been published by Winterbourn, et al. and Olsen, et al. 16,42,53  
Both groups used a simplified reaction network of MPO (similar to Figure 2.4), along with 
rate constants and initial conditions that were either measured experimentally or determined 
from a best guess when not readily available in the literature.  Another issue of concern is 
that many of the rate constants found in the literature were not measured under biological 
conditions.  This would mean that simulations are only as good as the approximated rate 
constants and would require further investigation as the quality and quantity of kinetic data 
for MPO improves.  
 
Since the investigations of Petty, Olsen and Winterborn, much effort has been made to better 
understand the MPO reaction mechanism and its impact on the human immune response 
primarily because oscillatory reactions of MPO may be important in immunochemistry.  
Unfortunately, because large-volume reactors (0.2 mL and above) require inordinate amounts 
of enzyme for reactions at physiologically relevant concentrations, and because ordinary 
microfluidic systems suffer from wall scavenging of free radicals, to our knowledge, the only 
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experimental demonstration of in vitro MPO-catalyzed oscillations is the cited Olsen 
experiment.42  As a result of Olsen’s work, questions arose as to whether MPO redox 
dynamics drove these oscillations or whether Ca2+/AMP-driven oscillations72,73 were masters 
and redox waves phase-locked slaves to cell membrane-controlled transport-driven 
oscillations.  Obtaining definitive answers from discussion of interactions between calcium 
waves and MPO/redox oscillations is difficult due to the lack of reliable experimental 
systems where ion transport can be varied at will while the concentrations of Ca2+, inositol, 
MPO, oxidants, and reductants are varied.  Work in vivo is only suggestive, while theoretical 
work based on kinetics data involving only small subsets of the full set of species may miss 
synergistic effects in the reaction network.  Numerous rate constants, nominally for 
homogeneous reaction, have become available from the Obinger,74-84 Winterbourn,75, 85-105 
and Davies106 -134 groups, but many measurements may suffer from systematic error due to 
radical/wall interactions. 
 
Herein lies the importance in studying and understanding biochemical networks and enzyme 
kinetics.  It is clear that MPO is important to life’s cycle, but MPO and other single enzymes 
do not work alone or in a closed system.  What is important is to understand the kinetics of 
the networks in which the small molecules and MPO are involved.  As described above, 
much of the small-molecule chemistry, critical to both the intra- and extra-cellular MPO 
function, is sufficiently understood to allow for preliminary ex vivo understanding, but to 
date, much about MPO in vivo has yet to be discovered.  Current research is aimed at gaining 
sufficient knowledge of these specific enzyme kinetics to learn how best to regulate these 
biochemical reactions through manipulation of endogenous species concentrations rather 
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than through development of novel compounds.  Knowledge of these kinetics will also allow 
for the development of models that may indicate how to initiate in vivo biochemical 
oscillations, suppress them, or control their frequency and amplitude.  Since oscillatory 
generation of reactive oxygen species has been correlated with killing of cancer cells,1, 5, 135 
such control could prove important for fighting disease. One very important improvement 
will need to be the development and the utilization of clean and robust instrumentation to 
obtain experimental data for calculating accurate rate constants. 
 
2.3 Studying Enzyme Kinetics: Macro vs. Micro Reaction Methods  
Typical Reaction Methods  
Accurate measurement of enzyme kinetics is an essential part of understanding the 
mechanisms of biochemical reactions.  The typical means of studying such systems is using 
milliliter sized reactors, a microfluidic system on a chip, a stopped-flow system, or other 
small sample holder.  With these setups, typically between 0.1 and 1 mL of reactant solution 
is needed per experiment.  When studying oscillatory reactions, the use of milliliter volumes 
of enzyme-containing solution per experiment has proven to be expensive, except for the 
particularly widely-available, plant-derived HRP.42  A shift to microfluidics is an approach 
that is being explored by many to overcome this problem. 
 
Especially with microfluidic systems, typical reaction vessels have walls that interact with 
molecules of systems under study and thus potentially alter their reaction kinetics.  Major 
concerns include adsorption of reactants and products to the walls of the reaction vessel,136-
144  wall catalyzed recombination,145 difficulty in maintaining homogeneity,146 and difficulty 
 18 
in maintaining good gas-liquid interface mass transfer (for reactions that produce or consume 
such species as O2, CO2, or CH4).  Using such systems would prove problematic for enzyme 
systems such as MPO which is cationic at neutral pH (and so can adsorb on glass or quartz, 
which is anionic above pH 3), consumes O2, and generates free radicals.   
 
In our lab, Lewis and Ruane showed that oscillatory chemistry in a macroscopic system is 
complicated by wall reactions.147  The study revealed that biofilms form on the quartz reactor 
surface in less than 48 hours after cleaning with NoChromex under conditions used for the 
HRP-catalyzed peroxidase-oxidase reaction.  As a result of the biofilms present, the 
nominally homogeneous peroxidase system exhibited dynamical changes over time that 
differed from that obtained when using different cleaning procedures in our laboratory and 
from that observed in other laboratories in, e.g., Indianapolis, IN, Palo Alto, CA, and Odense, 
Denmark.  The study also suggested that bare quartz also interacts with reaction species. 
These studies make clear that wall interaction and surface area-to-volume ratio are important 
parameters on which the observed dynamics depend. (Figure 2.6)  As the dimensions of 
reactor vessels become smaller (go from macro to micro), surface area-to-volume ratio 
increases, the effect of wall interactions become more important, and the assumption of 
homogeneity in a system becomes less assured.    
 
 
The quartz reactor turned out to be a receptive environment for the formation of biofilms.147  
Biofilms are structures built by and containing microorganisms that adhere to living and inert 
surfaces. Biofilms can and will interact with a variety of substrates and enzymes and are a 
highly dynamic system.  Biofilms interact with enzymes in an unknown fashion, resulting in 
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inconsistent results and poor correlation to biological environments.147  Scanning Electron 
Microscopy (SEM) was used to collect images of the biofilms (Figure 2.7) found by Lewis, 
Ruane and Scheeline when using their 5 mL quartz cuvette system, equipped with inlets and 
outlets for reactants and a stirring rod, to study the Peroxidase-Oxidase oscillatory reaction.  
As mentioned above, surface treatments can be used to minimize the effect of biofilms in 
flow reactors, but they do not eliminate all effects.  In many cases, they may further 
complicate the system.   
 
MPO’s reaction network, as well as those of many enzymes, involves a large number of 
reactions in which radicals are either reactants or products.  This is a problem for quartz 
cuvettes, which have been known to scavenge free radicals from solution. Since quartz is not 
present in vivo, it is important to develop an in vitro measurement system that will closely 
represent in vivo conditions.  A wall-less reaction vessel would work best. Both biofilm 
formation and radical scavenging would be eliminated in a wall-less system. 
 
Levitation: What is it, and why are we interested?   
As a way to circumvent the problems exhibited by other reactor types, our lab has developed 
an alternative approach to studying enzyme-catalyzed kinetics related to free radical and 
oxidative-stress chemistry.  Christopher Field and I have designed, built and characterized an 
Acoustically Levitated Drop Reactor (LDR) to use as a microreactor.71  With the LDR, an 
acoustic wave, produced by a piezoelectric transducer, is reflected by a metallic reflector or 
quartz window, creating a standing wave.  Drops levitate just below the nodes in this field.  
Details regarding optimal levitator design are debatable, but the theory is largely 
 20 
understood.148, 149 
 
Levitation is not a new concept.  Over the past 15 years, several experiments have been 
performed in levitated drops including fluorescence measurements, supercritical fluid studies 
and droplet dynamics.  It was not until 2003-2005 that levitators were considered for use in 
studying biochemical reactions.150  There are four main types of levitation; magnetic, 
electrostatic,151-154  optical,155,156 and acoustic.157,158 
 
Electrostatic and magnetic levitation generally used in, and are most suitable for, non-contact 
handling applications.152,153 Magnetic and electrostatic levitation have been used in a variety 
of applications including bearings, transportation systems and precision actuators.  
 
Optical levitation159 is the leviation of an object within two standing-wave optical modes of a 
Fabry-Perot cavity.  One large trapping beam provides an optical potential that traps the 
object near an antinode.  Alternatively, optical pressure from an upwardly-directed laser may 
support a particle absent a resonant cavity.  A second more weakly driven cavity mode with a 
nonvanishing intensity gradient at the trap center is used to cool the motion of the object.  
Optical Levitation is most often used for studying microparticles and to achieve enhanced 
micromanipulation of those particles.160  Optical levitation has also been considered for use 
in droplet science and studies of aerosols.161,162 
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Acoustic levitation, as mentioned before, uses a standing acoustic wave.  Of the various types 
of levitation, acoustic levitation offers several advantages for studying enzyme kinetics.  The 
lack of magnetic force, electrical charge, or light pressure ensures that there is no added 
interference or complexity from additional interactions to the already complex enzyme 
catalyzed reactions.  Nanoliter to microliter drops levitate just below the nodes in this field.  
The sample volume (and mass) required for experiments is reduced by more than 1000 times 
compared to that of an experiment with a macroscale reactor.  Additional advantages of 
acoustic levitation are the prevention of chemical contamination between drops and external 
objects, and potentially increased analytical sensitivity, since no walls disturb detection.163,164  
There is also the added advantage of easy access for a wide range of optical, electrochemical, 
and (in some laboratories) mass-spectral diagnostics.165.166  This technique, first described in 
1933,167 has been used to study materials properties, the shape and stability of liquid drops,168 
single cell analysis, protein crystallization, and to perform sample preparation (acid-base 
titrations, liquid/liquid extractions, and solvent exchange).  Other examples are cited in 
Santesson et al.169  Other than of the static chemical systems that have been studied, there is 
only one example of use of levitated drops to study reaction kinetics prior to the work 
described in this thesis.  That is a study conducted by David Weis and coworkers, measuring 
the kinetics of alkaline phosphatase in supercooled water (T< 0˚C).150 
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2.4 An Acoustically Levitated Drop Reactor (LDR) 
The acoustic levitator designed and characterized in our lab, although not the first acoustic 
levitator built, is the most efficient of which we are aware and is completely computer 
controlled. (Figure 2.8)  The design was inspired by Weis’s levitator, but is more user-
friendly and versatile, making it useful for studying a variety of reaction systems.  Our 
levitator requires six major components to make it functional; 1) an ultrasound transducer, 2) 
an ultrasonic horn, 3) a radiating plate, 4) a reflector, 5) the electronics and 6) computer 
automation. 
 
1) The Ultrasound Transducer.  The sound wave necessary for acoustic levitation is 
generated by the use of a Langevin, or sandwich, ultrasound transducer.  Two 
piezoelectric ceramics (5.08 cm diameter, 0.318 cm thickness) are compressed 
between two metal blocks and a torque on the four compression nuts of 11.25 inch·lb 
is applied to prevent fatigue failure and to ensure good acoustic coupling with the 
metal blocks.  The pressure bias is achieved using a pair of flanges secured with four 
bolts on the ends of the blocks.  When a potential is applied longitudinally across the 
piezoelectrics, the ceramic crystals convert the electrical energy into mechanical 
energy, which results in mechanical motion or sound.  
 
2) The Ultrasound Horn.  A horn is used to focus and shape the ultrasound emitted from 
the transducer.  In our design, a stepped horn is used.  The stepped horn is designed in 
two quarter-wave blocks with horn radius smaller than transducer radius.  This design 
maximizes the standing wave amplitude at the tip if the horn.  The horn, the upper 
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transducer quarter-wave block, and the radiating plate are made from a single block 
of metal to ensure good coupling.  The horn is attached to the transducer using a pair 
of flanges. 
 
3) The Radiating Plate.  A metal radiating plate (2.54 cm diameter, 0.318 cm thickness) 
is attached to the end of the stepped horn.  This provides proper coupling of the 
ultrasound to the medium and provides a nodal structure for acoustic levitation.    
 
4) The Reflector.  A concave reflector, with a radius of curvature of 33 mm, is used to 
establish a standing wave between it and the radiating plate at 20.73 kHz in a 
medium, with in our case is typically ambient air.  The distance between the 
resonating plate and the reflector determines the reflector’s effectiveness, and the 
levitation positions (nodes) within the cavity.  Between the resonating plate and 
reflector, when a potential has been applied across the piezoelectrics, standing waves 
are generated and it is just below the nodes that microliter or smaller volumes of 
sample can be acoustically levitated.  In order to maintain levitation, the reflector 
must maintain a specific distance from the resonating plate.  Equations are used to 
determine the optimal distance based on the temperature, pressure, and relative 
humidity in the room.  All equations and specifics of the characterization of this 
instrument are discussed in detail in Christopher Field’s thesis.170 
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5) The Electronics.  Prior to the design of our LDR, acoustic levitators commonly used a 
function generator, a 200 W amplifier, and an impedance matching transformer to 
drive the piezoelectrics.  This cost on the order of $5000 just to generate enough 
power for acoustic levitation (mainly due to the cost of the adjustable, multi-tap 
transformer).  With our design, we utilize a function generator (Agilent Technologies, 
Inc.) and an in-house designed 15 W ten times gain amplifier based on a commercial 
power operational amplifier to achieve acoustic levitation.  With this design, the 
power needed to drive the piezoelectrics, capital cost, and the cost of operation, were 
reduced. 
 
6) Computer Automation.  The LDR is completely controlled using several 
programmed modules in LabView 8.0 (National Instruments, Inc).  All of the 
electronics mentioned above, in addition to all of the data acquisition hardware, are 
controlled using this computer software.  
 
The LDR designed in our lab has been functional and in use since late 2006 to explore 
opportunities for use of this instrument as a microreactor.  As long as the pressure on the 
piezoelectric/transducer sandwich is stable so that the resonance frequency of the assembly is 
constant, reliable operation has been achieved. 
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2.5 Sample Handling in an Acoustic Levitator: Drop Generation, 
Reactant Introduction, Maintenance and Fluid Removal 
 
The development of various sample handling, mixing, and detection techniques for use in 
levitation would potentially allow for the use of drops as microreactors and specifically the 
study of biochemical/enzyme kinetics.  Microliter-scale droplet generation, reactant 
introduction, maintenance and fluid removal are all important aspects in conducting reactions 
in a levitated drop.  With enzyme reactions, many reactants involved are costly, in limited 
supply, or have limited solubility.  Therefore small sample volumes, typically on the 
nanoliter scale, are required.   
 
Typically, gas chromatography (GC) syringes are used to form an initial drop in an acoustic 
levitation cavity.171,172  From there, drop-on-demand (DOD) dispensers are used to add 
additional reactants.  DOD technology is extremely valuable for the addition of high 
concentration species in small volumes.  Drops are typically removed from the cavity by 
cutting the power, allowing the drop to fall to the resonating plate and wiping the plate clean.  
Alternatively, a capillary can be plunged into the drop, followed by removal by aspiration. 
 
Although the aforementioned sample handling techniques are simple and achieve the goal of 
levitating drops that contain various reactants, there is room for improvement.  There is 
definitely room for innovation in the areas of drop introduction and drop removal.  With this 
in mind, our lab has explored a unique technique that could be used alone or in addition to 
the current methods to provide fluid handling to and from an acoustically levitated drop that 
operates as a microreactor.  The development of this system and implementation into the 
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LDR as a drop formation system, using surface-coated capillary bundles, is the central 
instrument development reported in this thesis; see Chapter 3.     
 
2.6 Summary 
Understanding how the immune system operates, normally and when under attack, is very 
important in biology and medicine. Current research is aimed at understanding of specific 
enzyme-catalyzed oscillating reactions that generate reactive oxygen species, in order to 
regulate them.173  This can potentially lead to more enhanced and personalized drug therapy.   
Studying enzyme-catalyzed reactions using standard reaction systems requires large sample 
sizes. Conventional micro-scale reactors have high surface-to-volume ratios, and have been 
found to alter kinetics.  Our lab designed and characterized the most efficient and computer 
controlled, acoustically levitated drop system for use as a microreactor.  In addition, we have 
developed a unique sample handling system for proper fluid handing in the LDR.  The LDR 
has been discussed in my predecessor’s thesis. This thesis describes the sample handling 
system and its use in studying a variety of chemical kinetics, including enzyme-catalyzed 
kinetics.  Throughout the chapters, the advantages and challenges of using this system will 
also be discussed along with future directions for development of the LDR, the sample 
handling system, and kinetic studies.  
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Figure 2.1  A) A cartoon representation of the reactions occurring 
within an activated neutrophil which will generate toxic oxidants to 
destroy foreign microorganisms. Reprinted from Current Opinion in 
Microbiology, 7, Mayer-Scholl, A. et al., “How Do Neutrophils and 
Pathogens Interact?,” 62, 2004 with permission from Elsevier publishing.  
2.8        Chapter 2 Figures 
55 
Figure 2.2  A) Crystal structure of MPO emphasizing B) the non-polar 
porphyrin ring in MPO and its covalent attachments to the preotein via two ester 
bonds.  Reprinted from the Annual Review of Immunology, 23, Segal, A., “How 
Neutrophils Kill Microbes,” 197, 2005, with permission of Annual Reviews.  
56 
Figure 2.3  A cartoon representation of the steps involved in a macrophage 
ingesting and killing a pathogen.  Reproduced from New Scientist, 1605, “The 
Human Immune System: The Lymphocyte Story,” 1, 1988 with permission of 
Elsevier publishing. 
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A. 
B. 
Figure 2.4  A) Products of the MPO-mediated antimicrobial system and the B) 
MPO complex formation.  Reproduced from the Journal of Leukocyte Biology, 77, 
Klebanoff, S.J., “Myeloperoxidase: Friend or Foe,” 598, 2005, with permission of 
the Federation of American Societies for Experimental Biology. 
58 
Figure 2.5  List of reactions in the simplified reaction network of MPO. 
Units on rate constants are s-1 for first-order reactions and M-1s-1 for second-
order reactions. Reprinted from the Journal of Biological Chemistry, 281, 
Winterborn, C. C. et al., “Modeling the Reactions of Superoxide and 
Myeloperoxidase in the Neutrophil Phagosome,” 39860, 2006, with 
permission from ASBMB publications. 
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Figure 2.6. Fluctuations in [O2] in the PO oscillator for various reactor compositions.  
Reprinted, with permission, from  Dean Olson’s thesis (personal communication).  
60 
Figure 2.7 A pair of scanning electron microscopy images of biofilm formation 
on quartz slides. Reproduced with permission from Christopher Ryan Field’s PhD 
dissertation, 2009, University of Illinois Urbana-Champaign.  Original data 
obtained by D. D. Lewis and M. L. Ruane. 
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Figure 2.8 Details of the Acoustically-Levitated Drop Reactor with labeled 
components. Alibre drawing generated by Christopher Field in Scheeline 
Research Group.  Reprinted with permission via personal communication. 
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CHAPTER 3 
SAMPLE HANDLING AND CHEMICAL KINETICS:                         
AN ACOUSTICALLY LEVITATED DROP AS A 
MICROREACTOR 
	  
	  
Much of this chapter, coauthored by Christopher R. Field and Alexander Scheeline, has been 
previously published in Analytical Chemistry, 81(20), 8496-8502 (2009) DOI: 
10.1021/ac901400y.  While Field and Scheeline contributed helpful suggestions to the work, 
all fluidics apparatus are of my construction and I obtained all kinetics data.  Additional 
figures and material have been added to note changes and provide additional clarity.  
Figures from the above publication have been noted and reprinted with permission of the 
publisher.     
	  
3.1 Introduction 
In an effort to thoroughly understand the mechanisms of biochemical reactions, accurate 
measurement of enzyme kinetics is essential.  Common methods used to study reaction 
systems employ stirred cuvettes, stopped-flow systems, lab-on-a chip/microfluidic flow 
channels, or some other sample container together with an appropriate monitoring system.1-3  
With many of the standard reaction rate methods, adsorption of reactants and products to the 
walls of the reaction vessel proves problematic.  Reaction rates may be altered by biofilm 
buildup on reactor walls.4  In an effort to avoid such problems, we report the use of an 
acoustically levitated drop reactor (LDR).5  Precedent measurements of kinetics in levitated 
drops include work by David Weis and others.12-14 
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In order to achieve such reactions in a levitated drop, droplet generation and sample delivery 
with minimal sample loss, is important.  Most research employing levitators uses syringes, 
pipettes or picoliter (pL) drop-on demand ballistic injection.  In the present study, we 
investigated the efficiency of using an Acoustically-Levitated Drop Reactor (LDR) (Figure 
3.1) to study reaction kinetics coupled with a pressure driven capillary bundle system to 
achieve sample introduction, mixing, drop maintenance, and fluid removal.   
 
Kinetics measurements for both luminol chemiluminescence and lactate dehydrogenase 
(LDH) catalyzed reaction of NADH with pyruvate were conducted.  These reactions have 
been studied previously and are well understood.25-27  By studying these reactions, we were 
able to evaluate both the advantages and challenges of running reactions in an LDR.  We 
address questions such as the degree of mixing in the drop, correspondence of luminescence 
in a 5 mL capillary-fed drop to that expected in larger reactors, and how long a drop can be 
maintained.   
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3.2 Materials and Methods 
Materials.  All reagents were purchased from either Sigma-Aldrich (St. Louis, MO) or Fisher 
Scientific (Fair Lawn, NJ), unless otherwise noted.    
For chemiluminescence experiments, solutions of 0.07 M luminol (CAS 521-31-3), 3.0 M 
sodium bicarbonate (NaHCO3, CAS 144-55-8), 0.5 M sodium carbonate (Na2CO3, CAS 497-
19-8), 0.05 M ammonium carbonate ((NH4)2CO3, CAS 506-87-6), 0.015 M copper II sulfate 
(CuSO4, CAS 7758-98-7) and 0.10% hydrogen peroxide (H2O2, CAS 144-55-8) were 
prepared using 18-MΩ ultrapure water purified using a Q-POD ultrapure water filtration 
system (ZMQSP0D02, Millipore, Billerica, MA).  Reagents were both prepared and stored at 
room temperature.  Literature concentrations and procedures were modified so that reaction 
would occur at a measurable rate in a 5 µL drop.28  When running experiments, 0.2 mL of 
luminol, NaHCO3, Na2CO3, (NH4)2CO3, and CuSO4 solutions were each added to one sample 
injection vial, while 1 mL of H2O2 solution was added to a second.  For each run, 2.5 µL of 
the luminol mixture was injected into the LDR followed by 2.5 µL of H2O2.   
For the enzyme-catalyzed fluorescence experiments, solutions of 1 mM sodium pyruvate 
(CAS 113-24-06), 0.15 mM nicotinamide adenine dinucleotide, reduced form (NADH, CAS 
606-68-8), 0.25units/mL of L-lactate dehydrogenase (LDH, CAS 9001-60-9), 0.1% w/v 
poly-L-lysine, MW 150,000 – 300,000 (CAS 25988-63-0), and 0.25 mM bovine serum 
albumin (BSA, CAS 9048-46-8) were prepared, separately, in 0.1 M 1X-phosphate buffer 
solution (PBS, CAS 7558-79-4) (HyClone, Logan, UT).  All reagents, except LDH, were 
refrigerated (10 ˚C) when not in use.  LDH was frozen (-20 ˚C).  Solution preparation and 
reaction procedures were detailed previously.29  When running experiments, 0.75 mL each of 
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sodium pyruvate and NADH solutions were each added to one injection vial and 1.5 mL 
LDH to the second.  For each run, a 4 µL drop was generated for reaction; 3.5 µL of the 
NADH mixture was injected into the LDR followed by 0.5 µL of LDH solution.  To prevent 
LDH from adhering to the walls of the pipette tips, when transferring it from stock solution 
to LDR sample vials, transfer pipette tips were coated with BSA before each transfer.  
CYTOP® (ASAHI Glass Company. Maiden, MA), a fluorinated polymer, with a contact 
angle of greater than 110°, was applied to the outer surface of the capillaries to provide a 
super-hydrophobic outer coating so that the drops would not wick to the sides of the 
capillaries.  Walls of capillaries used to convey LDH were coated with poly-L-lysine30 by 
pumping a 0.01% solution through capillaries following cleaning with piranha solution (3 
parts concentrated H2SO4, 1 part H2O2).  Warning: piranha solution is a strong oxidant, must 
be kept away from significant quantities of oxidizable organic compounds, and must be 
disposed of by careful neutralization. 
 
LDR Setup and Capillary Positioning. Before drops are introduced into the LDR via the 
capillary system, the capillaries must be positioned within one millimeter of the LDR 
pressure node.  This is achieved by first manipulating the levitator so that it is optimized for 
levitation.  Optimized levitation means the drop is as positionally stable as possible in the 
levitation cavity, close to a spherical shape, and with shape fluctuations.  Using a LabView 
8.0 module (see Appendix), the levitator is activated.  Next, temperature, pressure, and 
humidity are recorded, and reflector height computed as previously described.5   A syringe is 
used to introduce a 5 µL drop into the LDR.  This drop is used as a guide for the tip of the 
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capillary system to indicate the optimal position for delivering reactants.  This procedure 
only has to be completed once daily. 
 
Sample Introduction.  Sample introduction was achieved using a Poiseuille flow capillary 
system developed in-house (Figure 3.2).  The setup consists of a polyamide adhered, poly-L-
lysine (PLL) flushed, CYTOP®-coated, capillary bundle to deliver the initial drop to the 
levitator, add reactants, and remove the droplet once reacted.  The capillary bundle is made 
of three 1 m long, 363 µm OD, 180 µm ID, flexible fused silica capillaries from Polymicro 
Technologies (Phoenix, AZ).  They are adhered to one another using a polyimide resin (CAS 
68410-23-1).  Each capillary is connected to a 2 mL vial using a series of PEEK® fittings, 
ferrules, unions and tubing sleeves (Upchurch Scientific, model numbers F33NX, P-702, P-
440, and F-238X), in which reagents can be placed for delivery to the LDR or from which 
waste can be collected.  0.01 % w/v PLL in 0.1 M Phosphate buffer is flushed through the 
capillaries to coat the inner walls of the capillaries to eliminate cationic enzyme adsorption or 
build-up on the walls.  The coated capillaries are used for up to 60 reaction runs before 
flushing with PLL again.  The capillary bundle is positioned in the LDR using an XYZ stage 
(TSX-1A, Newport, Irvine, CA).  
Fluids are fed into the levitator through two of the capillaries in the bundle using pressurized 
argon (40 psi) and a drop is formed on the tip of the capillaries.  The inlet flow rate is 
2.3 µL/s.  A belt driven, HYVAC vacuum pump (-12 psi, 600 rpm, CENCO, New Brighton, 
MN) is connected to the third capillary in the bundle.  A 1-mL vial, used to collect the 
sample waste as drops are removed, is positioned between the capillary and the pump.  A 
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series of two-way, 5V solenoid valves (Precision Dynamics, Inc. New Britain, CT) is used on 
each capillary line to control the fluid flow.  This stopped-flow system is controlled using a 
program written in LabVIEW 8.0.  Solenoid drivers are connected directly to the digital 
outputs on a multifunction analog-to-digital (ADC) card (PCI-DAS6014, Measurement 
Computing Inc., Norton, MA).  The program allows for the injection of fluids from the 
sample vials sequentially within seconds with the click of one button on the LabVIEW 
module screen.  Drops are removed from the LDR in the same way.  Without using the 
vacuum to remove the drop, a  5 µL levitated drop will evaporate completely from the tip of 
the capillaries within 6 minutes in a dry atmosphere close to room temperature, 23°C.  For 
the experiments conducted in this paper, all reactions were complete within 1 min. 
Kinetics Measurements. The kinetic measurements for the luminol chemiluminescence and 
NADH fluorescence were performed using the LDR detailed previously.5   Since that 
publication, foot switches (model FTSW-SM, MicroRidge, Sunriver, OR) were added to  
allow hands-free, fine-tuning adjustments (0.01 mm increments, up and down) of the 
reflector height  for optimum levitation.  Initially, a closed-circuit digital camera (CCTV 
Camera, 24 V AC 60Hz 3.4 W, UltraLum, Claremont, CA) and television (model WV-BM-
990, Panasonic, Secaucus, NJ) were used to view the levitation cavity.  This was later 
replaced with a higher speed CMOS camera (Stingray IEEE1394 C-Mount Camera, Allied 
Vision Technologies GmbH,  Stadtroda/Germany), coupled with a 0.63× magnification 
telecentric lens (Invarigon 59 LGU 042 with 59 LGZ 415 teleconverter, CVI/Melles Griot, 
Covina, CA) to better view the levitation cavity during experiments in real time.  
Temperature, pressure, humidity, levitation bimorph drive voltage, and reflector height were 
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recorded before each run.  Measurements were carried out close to room temperature. 
For the chemiluminescence experiments, the time course of the luminol reaction with H2O2 
was detected using a 910 µm core diameter fiber optic (BFH22-910, ThorLabs. Newton, NJ) 
coupled to a photomultiplier tube (PMT) (R928, Hamamatsu. Bridgewater, NJ) with a 
variable high voltage supply (model 205A-01R, Bertan Associates), set to 375 V (Figure 3.1 
A).  The output current from the PMT was sensed through a 1V/µA linear amplifier.  The 
signal output from the amplifier was T-ed to an oscilloscope (7603, Tektronix, 7A14 plug-in) 
through a 1 MΩ signal input and to the same multifunction ADC used for solenoid valve 
control mentioned earlier.  The ADC was configured with 16 analog single-ended inputs.  A 
data acquisition program was written in LabVIEW 8.0 (National Instruments. Austin, TX) 
using the Measurement Computing Universal Library for LabVIEW to collect, save, and 
display the PMT signal.  The time course of the intensity change was fitted to a second order 
rate law. 
For the NADH fluorescence, either a 200 mW 357 nm argon ion laser (Innova 90, Coherent 
Inc.,  Santa Clara, CA) or a 16 mW, 372 nm wavelength diode laser (1Q micro 1A, Model 
LDCU8/8940, Power Technologies Inc. Alexander, AR) was used for excitation (See ‘Note’ 
at end of Chapter for clarification).  Reaction concentrations, sampling rate (1kHz), total 
sampling time (30s), and the fiber optic detection system were the same for both sets of 
experiments. 
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3.3 Results and Discussion 
Microfluidic Setup. The LDR functions as a stirred batch microreactor with convection 
induced by the ultrasound.20  In order for this system to function properly, the capillary 
system explained in the previous section is vital.  The 3-capillary bundle system (Figure 3.1 
B) provides the means to introduce samples into the LDR, in part to mix reactants, and to 
remove spent drops.  The orientation of the capillaries is very important to the success of 
experiments.  Reactants can be delivered or removed from any capillary, but the capillaries 
must be positioned so that there are two capillaries with axes parallel to the earth’s surface 
and at equal height, with the third capillary at the bottom (Figure 3.2).  Improper orientation 
results in wicking of the drop to the side of the capillary bundle.  Even with proper 
orientation, it is essential to coat the capillary tip with CYTOP® to prevent drop adhesion. 
Reactants are introduced sequentially from the capillaries.  Mixing in the drop appears to be 
effectively complete in less than one second, as is discussed below concerning the 
chemiluminescence experiments.  Without adequate mixing of H2O2 into a pre-existing 
luminol/Cu2+ solution drop, homogenous emission would not have been observed.  The 2.3 
µL/s rate at which reactants are introduced contributes to drop rotation and mixing.  Details 
are shown in Figure 3.3.    
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Chemiluminescence Experiments. Typical chemiluminescence data are shown in Figure 3.3.  
The reactions are: 
Cu2+ + luminol               Cu2+luminol                                      (3.1) 
Cu2+luminol + H2O2             Cu2+ + 4-aminophthalate*          (3.2) 
4-aminophthalate*            4-aminophthalate + hν                     (3.3) 
 
The primary reasons for performing these experiments were to demonstrate that reactions 
initiated by reactant flow from capillaries could be observed in the drop, and that reactant 
mixing in the LDR from diffusion, flow-induced convection, and ultrasound-induced 
circulation was sufficiently rapid to be useful for study on a second or faster time scale.  Data 
seen in Figure 3.3 and the still images extracted from one of the runs (Figure 3.5) show that 
mixing is essentially complete within 1 s after reactant influx is stopped, as emission appears 
to be uniform throughout the drop.  
 
Figure 3.3A shows a single raw data transient, one of eight chemiluminescence experiments 
in a successful data set.  The reaction is nearly complete within 15 seconds.  Figure 3B is an 
inset of Figure 3.3A that shows the last second of the luminol/Cu2+ solution feed and the 
introduction of the H2O2.  As the H2O2 is introduced at ~ t = 3 s, the drop begins to 
luminesce, causing a sharp increase in the photocurrent.  Each chemiluminescence transient 
showed baseline offset (Figure 3.3C) from one run to the next that was trivially corrected 
(Figure 3.3D).  While valve switching is precise to better than 0.1 s, mixing time varies from 
0.5 to 1.5 s.  Inset D of Figure 3.3 shows every trace offset to a common baseline, with 
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transients shifted in time so that all decays go through 0.4 µA simultaneously.   
 
Averaging all the traces in D, one obtains Inset E.  If the decay were a pure second-order 
reaction between luminol and H2O2 with the effect of Cu2+ limited to increasing the pseudo-
second order rate constant k2, the fluorescence intensity would follow a time course,  
I =
Fk BA (B! A)
2e(B!A)kt
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A e
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2    (3.4) 
where A = [luminol]0, B = [H2O2]0, F is an arbitrary scale factor dependent on observation 
system and reaction quantum yield, and k is an effective rate constant, dependent at least on 
pH, ionic strength, and [Cu2+].  By design, B>A.  As expressed here, (B-A) can either be 
computed from the initial values of A and B or used as a separate fitting parameter.  When it 
is separately optimized, one obtains the best possible fits.  Obviously, an alternative 
interpretation is that the rate law governing chemiluminescence is more complicated than 
pure second order.  Yu et al. postulate a mechanism that would be at least third order or 
involve a pre-equilibrium.31  The point here is not to elucidate the mechanistic details but 
rather to demonstrate that such elucidation is plausible with this apparatus.   
 
In Figure 3.4, one can see that as H2O2 is delivered to the cavity within the first 2.5 seconds, 
the relative standard deviation (RSD), from averaging the 6 transients, is extremely high; at 
several times reaching as high as 1000% RSD. After 2.5 s, where the luminol has begun to 
flow into the drop, the RSD drops to below 20%.  Once the luminol delivery was complete, 
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at 4.5 s, the RSD dropped to its lowest of 1%.  As reaction continued in the drop for the final 
10 seconds, the RSD gradually increased at a rate of 1% s-1, ending at 10%.  Figure 3.4 
shows that the reproducibility other than baseline and initiation time offsets (Figure 3.3D) 
can be seen to be less than 10% once mixing is complete.  
Figure 3.5 shows individual frames from a video recording of a luminescence transient.  
Between 1 and 2.97 s there is heterogeneity within the drop.  As the H2O2 is introduced, 
beginning at 3.05 s, the drop begins to gradually illuminate in a non-uniform manner.  
Circulation from solution introduction causes the drop to precess in a circular motion which 
ultimately results in a well mixed drop that reaches maximum intensity at 3.7 s, and only 0.7 
s after completion of H2O2 introduction.  At 3.7 s there is a noticeable decrease in intensity 
that rebounds at both 4.0 and 4.1 s, neither reaching the intensity observed at 3.7 s.  After 4.2 
s, the drop luminescence intensity steadily decreases.  Between 7.34 s and 10.23 s, a great 
difference in drop intensity can be seen.  In addition to the intensity changes, inhomogeneity 
can be seen over time.  At 3.13 s, the ripples in the drop are evidence of mixing.  For each 
time noted on the plot beyond 3.13 s, small drop modulations are observed.  Figure 3.3 inset 
F shows that some small signal modulation inconsistent with a pure mass-action, monotonic 
approach to equilibrium is observed.  Whether this "hump" is due entirely to drop 
inhomogeneity or if dust or some other source causes this modulation has not been 
determined.  
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LDH Experiments:  NADH/LDH/Pyruvate kinetic data can be seen in Figures 3.6 and 3.7.  
The reaction is  
NADH + Pyruvate + H+             NAD+ + lactate  (3.5) 
where LDH catalyzes the reduction of pyruvate to lactate using NADH in the LDR.  
Attempts to study this well-known reaction presented several difficulties.  Although a 
difference is observed between the transients of reacting samples and these of water or 
nonreacting NADH, reproducibility between runs was difficult to obtain.  When a run was 
successful, it followed Michaelis-Menten32 kinetics remarkably well, as detailed below.  
Figures 3.6 and 3.7 show LDH experiments from two series of drops formed at 1 min 
intervals without changing levitation parameters (See ‘Note’ at end of chapter for 
clarification).  Figure 3.6A shows fluorescence from a blank, a 4 µL drop of 18 MΩ 
deionized water.  Figure 3.6B shows the transient for a newly formed drop that contains only 
NADH.  Besides the intensity increase as a result of the NADH fluorescence, the drop is 
relatively stable and exhibits little change over the 30 second observation period.  This 
demonstrates that NADH fluorescence is steady when laser-excited but when no pyruvate or 
enzyme is present.   
Figures 3.6 A-C and E and Figures 3.7 A-C present our most recent LDH experiments.  The 
LDR parameters were: reflector height (17.463 mm), transducer amplifier drive (4.6 Vpp), 
temperature (27.5 ˚C), humidity (15.1%), and pressure (980.8 mbar).  For detection, PMT 
voltage was set to 450 V.  Illumination was with the Power Technologies diode laser.  
Figures 3.6D and F and 3.7 D-F are representative of LDH experiments conducted a year 
earlier.  The LDR parameters for these reactions were: reflector height (17.463 mm), 
LDH	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transducer amplifier drive (6.2 Vpp), temperature (22.2 ˚C), humidity (22.9%), and pressure 
(996.1 mbar).  The 357 nm, 200 mW argon ion laser was used for NADH excitation.  The 
PMT voltage was set much lower for this laser, at 325 V.  Reaction concentrations, sampling 
rate (1 kHz), total sampling time (30 s), and fiber optic detection system were the same for 
both sets of experiments.  
Figures 3.6C and D show data from successful LDH runs.  Within the first four seconds, the 
NADH/Pyruvate mixture and LDH have formed a levitating drop and have begun reacting.  
As the NADH and pyruvate are consumed, the signal decays.  Each transient reaches a steady 
state as all of the pyruvate and approximately 10% of the NADH are consumed.  If all of the 
NADH had been consumed the signal intensity would have eventually dropped to zero; 
instead the intensity drops by about 20% in each case.  Figures 3.6 A-C and E exhibit the 
same high frequency fluctuations.  We attribute the majority of the fluctuations to shot noise.  
The Savitzky-Golay33 algorithm was used to filter the data.  
While we attempted to derive a rate law and integrated rate expression based on an extensive 
set of fundamental reactions in this system, the number of fitting parameters exceeded what 
could be statistically justified from the noisy data.  This is hardly a novel problem.34   
 
We thus approximated the reaction model as pure Michaelis-Menten, with pyruvate as the 
kinetically-limiting substrate,  
][
][][ max
pyruvateK
pyruvateV
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lactated
M +
=    (3.6) 
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where Km and Vmax have the usual meanings of substrate binding constant and maximum 
reaction rate, ignoring product inhibition.   
dt
pyruvated
dt
lactated
dt
NADd ][][][
!==
+
  (3.7) 
By conservation of matter, 
[NADH] = [NADH]0 – [lactate]  (3.8) 
Integration of equation 6 gives: 
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This is conveniently rewritten in terms of the fraction of reaction completed, f. 
( )f
V
K
V
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0    (3.10) 
Vmax is known from the assay of enzyme used in the reaction, so KM is the free fitting 
parameter.  Equations 8 and 10 were used iteratively to fit the data in Figures 3.6C and D.  
Data in Figure 3.6C was offset to a zero baseline.  The experimental concentration of 
substrate, enzyme concentration, and time were used as parameters to generate the fitted 
decay of Figures 3.6C and D, as shown in Figures 3.6E and F.  The fitted KM, 0.2 µM,35 
matched literature values under the conditions used, offering validation that the LDR could 
serve, at least in this case, as a useful microreactor for studying biochemical reactions.  The 
reaction in the 5 µL drop in the LDR, in a volume comparable to other microfluidic systems 
and orders of magnitude smaller than conventional systems, provides the same data as a 
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macroscopic system.  It is important to note that the reactions were conducted without active 
environmental controls (temperature, pressure, humidity, etc.) other than the approximate 
regulation provided by building heating systems.  Nevertheless, results were reproducible.   
 
The data in Figure 3.6 demonstrates the potential for LDRs to be used as microreactors.  
Figure 3.7, on the other hand, presents several non-idealities of the LDR system that must be 
understood and rectified, if possible, before the system will offer the reproducibility expected 
in a routinely useful instrumental system.  Contributions to these non-idealities in drop signal 
in addition to the obvious shot noise include rapid spinning of the drop, breathing modes of 
the drop, bubble formation and dissipation and scattering from debris present in the drop.  
Examples of these other phenomena in drops have been previously documented.36, 37  Figure 
3.7 shows three examples of non-idealities in the drops, classified using images obtained 
using the CMOS camera.  
 
In Figures 3.7 A-F, each drop exhibited bubbles forming as the drop was being generated; 
these eventually dissipated.  For droplets that have bubbles present, whether large or small, 
stationary or in-motion, random increases in intensity and large frequency fluctuations in the 
samples are observed (Figure 3.7A and D).  When a droplet is breathing, expanding up and 
down or side to side, dips and valleys are present as seen in Figures 3.7B and E.  Although 
the signal is compromised as a result of the breathing motions of the drop, convection is 
necessary to mix the reactants and burst the bubbles to form a homogeneous drop.  Spinning 
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of the drop also aids in the mixing of the drop’s contents; spinning rapidly correlates with 
noisy signals from the drop.  When a drop is spinning, evenly spaced sharp increases in 
intensity appear as in Figure 3.7B and E.  Being able to recognize these nonidealities will 
allow development of ways to reduce or eliminate them. 
 
Limitations and Improvements.  A number of changes to the LDR system are required to 
make it useful for its design purpose of studying kinetics of enzyme reactions involving 
reactive oxygen species.  Active temperature and humidity controls are being added.  
Improvements in sample introduction using ballistic injection of "drops on demand" are also 
in process.  Understanding and optimizing mixing of separate reactant streams (whether 
continuous from capillaries or discrete from droplet injection38, 39) is critical.  While mixing 
times ~ 0.5 s are useful for some experiments, times below 0.1 s are necessary for study of 
many free-radical systems, and times below 0.01 s are necessary to be competitive with, e.g., 
stopped-flow systems.   
 
	   
78 
3.4 Conclusions 
This chapter demonstrated that a LDR can be used to obtain enzyme and other reaction 
kinetics data in a system free of solid-liquid interfaces.  Success at such measurements has 
been shown for LDH.  Also noted briefly were drop stability, mixing, and instrument 
limitations, most of which can be remedied with engineering improvements.  Some 
improvements are discussed in the next chapter.  Chapter 5 includes more detail on the 
limitations of the LDR and suggestions for future engineering and experiments that can be 
used to address those issues. 
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Note (as cited in text) 
 
LDH Experimental Data   
 
The LDH experiment data presented in this paper were collected on two different dates using 
different lasers; a 200 mW 357 nm argon ion laser (Innova 90, Coherent Inc. Santa Clara, 
CA) or a 16 mW, 372 nm wavelength diode laser (1Q micro 1A, Model LDCU8/8940, Power 
Technologies Inc. Alexander, AR).  Figures 3.4 and 3.5 contain data from both series of data. 
Data obtained using the argon laser is presented in Figures 3.4D, 3.4F and 3.5D-F. Levitation 
parameters were: reflector height (17.46 mm), transducer amplifier drive (6.2 Vpp), 
temperature (22.2 ºC), humidity (22.9%), and pressure (996.1 mbar). PMT voltage was set to 
450 V. 
  
Due to failure of the 200 mW laser, the 16 mW, 372 nm wavelength diode laser was used for 
the second series of data, which is presented in Figures 3.4A-C, 3.4E and 3.5A-C.  Levitation 
parameters for the diode laser were: reflector height (17.46 mm), transducer amplifier drive 
(4.6 Vpp), temperature (27.5 ºC), humidity (15.1%), and pressure (980.8 mbar). The PMT 
voltage was set reduced to 325 V.  Approximately one year transpired between the two sets 
of experiments. 
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Figure 3.1  Acoustic Levitation.  A. Schematic of the entire acoustic levitation 
drop reactor (aLDR) sysetm.  B. Levitation cavity setup of the aLDR.  Sample 
vials with connections to  silica fused  capillary bundles system.  Continuous wave 
argon laser, drop and optical detection system also shown.  Reprinted from 
Analytical Chemistry, 81, Pierre, Z., Field, C. and Scheeline, A., “Sample 
Handling and Chemical Kinetics in an Acoustically Levitated Drop Microreactor,” 
8496, 2009, with permission from ACS publications. 
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Figure  3.2  3-Capillary Bundle System.  Three 1 m, 180 µm ID fused 
silica capillaries bonded together with polyamide resin.  Orientation with 
two capillaries parallel to earth’s plane on the top and one capillary on the 
bottom is needed for successful experiments.  Reprinted from Analytical 
Chemistry, 81, Pierre, Z., Field, C. and Scheeline, A., “Sample Handling 
and Chemical Kinetics in an Acoustically Levitated Drop Microreactor,” 
8496, 2009, with permission from ACS publications. 
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Figure  3.3  Chemiluminescence Kinetics in Levitated Drops.  A.  Single 
chemiluminescence transient. Introduction of copper/luminol solution and H2O2 
solution are noted on the plot.  B. An inset of A showing luminescence during 
reaction initiation.  C. Six raw chemiluminescence transients.  D. Data from A, 
baseline and time-offset.  E. Average of data in D.  Fit to second-order rate law is 
"Consistent Fit."  Allowing [luminol]/[H2O2] to be fit independently from [luminol] – 
[H2O2] gives "Independent Fit."  F. Scale expansion of fits in Inset E.  Nonmonotonic 
decrease in luminescence data is evidence of dynamics other than simply mass-action 
kinetics.  Reprinted from Analytical Chemistry, 81, Pierre, Z., Field, C. and 
Scheeline, A., “Sample Handling and Chemical Kinetics in an Acoustically Levitated 
Drop Microreactor,” 8496, 2009, with permission from ACS publications. 
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Figure  3.4  Relative Standard Deviation of Light 
Emission During Drop Mixing During Chemiluminescence 
Experiment.  Red trace is ~ 20x scale expansion of blue 
trace.  Property of the Scheeline Reseaech Group. 
89 
Figure  3.5  Chemiluminescence Kinetics in Levitated Drops.  A single 
chemiluminescence transient with visual representation of the drops from 
individual frames of  a video recording of a luminescence  experiment.  
Photoinsets and photomultiplier traces are from the same experiment. 
Changes in the drop color intensity, size and shape can be seen over time.  
Reprinted from Analytical Chemistry, 81, Pierre, Z., Field, C. and Scheeline, 
A., “Sample Handling and Chemical Kinetics in an Acoustically Levitated 
Drop Microreactor,” 8496, 2009, with permission from ACS publications. 
90 
B	  
C	  
A	  
D	  
E	   F	  
Figure 3.6 Lactate Dehydrogenase Catalyzed Reduction of Pyruvate to Lactate in 
the LDR.  A. Transient of 18MΩ deionized water.  B. Transient in the absence of  
pyruvate. (NADH Only)  C. -D. Two 30-second  transients from runs in the LDR on 
different dates.  Each transient relaxes to steady state with consumption of all 
pyruvate and ~ 10% of NADH.   E.-F.  Represents the Michaelis-Menten fit for C and 
D, respectively. (Data smoothed using a 21 point Savitzky-Golay algorithm (A and 
B) and 51 points (C). D-F data was not smoothed.).  Reprinted from Analytical 
Chemistry, 81, Pierre, Z., Field, C. and Scheeline, A., “Sample Handling and 
Chemical Kinetics in an Acoustically Levitated Drop Microreactor,” 8496, 2009, 
with permission from ACS publications. 
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Figure 3.7 Drop Pathological Phenomena. A-F. Transients of Lactate 
Dehydrogenase Catalyzed Reduction of Pyruvate to Lactate in the LDR .  Drop 
breathing (A and C), bubble formation and dissipation (B and E) , and spinning (C 
and F) are all presented here.  Bubbles formed during drop generation; most dissipate 
within 15 s of drop formation.  Reprinted from Analytical Chemistry, 81, Pierre, Z., 
Field, C. and Scheeline, A., “Sample Handling and Chemical Kinetics in an 
Acoustically Levitated Drop Microreactor,” 8496, 2009, with permission from ACS 
publications. 
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CHAPTER 4 
 
STABILITY OF MYELOPEROXIDASE AT THE GAS/LIQUID 
INTERFACE 
Myeloperoxidase has been mentioned repeatedly in this thesis because it is the motivation 
behind much of the development of the LDR.  Although wall interactions are not a concern in 
the LDR system, there is the possibility for denaturing or instability of enzymes at the 
gas/liquid interface.  This chapter addresses the issue of Myeloperoxidase stability at the 
liquid/gas interface and in solution.    
 
4.1 Introduction 
Three-dimensional, biologically active structures of proteins are maintained by a fragile 
balance of electrostatic and hydrophobic interactions among the residues.1  For many 
proteins, the slightest imbalance in temperature, pH, surfactant, etc., causes denaturation and 
impairs its activity.  The primary reason this occurs is because of the way water-soluble 
proteins are arranged.  Their nonpolar, saturated hydrocarbons are buried in the interior while 
the surface is covered with polar groups.  When such a structure comes in contact with an 
interface, there is a strong tendency for the nonpolar parts to be attracted to the hydrophobic 
parts of the interface.  As a result, the protein undergoes a conformational rearrangement.  
This rearrangement, performed in order to maximize the number of favorable interactions, 
leads to unfolding of the protein; also known as surface denaturation.2  Surface denaturation 
of proteins has been studied by a variety of methods such as X-ray and neutron reflections,3 
sum frequency generation,4 conventional spectroscopic techniques,5 and the stability of 
proteins at the liquid/gas interface has also been discussed.2 
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If surface denaturation universally occurred, then even a fully-developed LDR to study 
enzyme-catalyzed reactions would be of little value.  Therefore this chapter details the 
investigation of surface denaturation of the protein Myeloperoxidase using both sum 
frequency generation (SFG) and UV-Vis spectroscopy.  The SFG (and associated surface 
tension measurement) work was done in collaboration with Professor Elsa Yan of Yale 
University.  Details of the work have not yet been published, so only results of the study will 
be presented here based on correspondence with Yan.  My contribution to the work was to 
test whether Yan's results were correlated with laser-induced photochemistry or if they were 
more likely were due to light-independent of photochemistry. 
 
4.2 Materials and Methods    
Materials.  All reagents for the buffer were purchased from Fisher Scientific (Fair Lawn, 
NJ).  A 100 mL stock solution of 0.1 M phosphate buffer (pH 7.0) was prepared from 30.5 
mL of 0.2 M sodium phosphate, dibasic, heptahydrate (Na2HPO4•7H2O, CAS 7782-85-6), 
19.5 mL of 0.2 M sodium phosphate monobasic monohydrate (NaH2PO4•H2O, CAS 10049-
21-5), and 50 mL of 18 MΩ ultrapure water purified using a Q-POD ultrapure water filtration 
system (ZMQSP0D02, Millipore, Billerica, MA).  The buffer was stored at room 
temperature. 
 
Myeloperoxidase (MPO) was obtained from Lee Biosolutions Inc. (St. Louis, MO).  The 
source of the MPO was from human neutrophils (CAS 9003-99-0, EC 1.11.1.7, 1 mg 
MPO/vial, > 98% purity by SDS-PAGE).   
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MPO was prepared directly in a 1 cm path length, micro volume (580 µL), Spectrosil® 
quartz spectrophotometer cell purchased from Starna Cells, Inc. (Catalog# 28/9/Q/10; 
Atascadero, CA).  The laser used for protein exposure was a 500 mW average power at 800 
nm, picosecond-pulsed, mode locked, Ti:Sapphire laser made by Spectra Physics (Model: 
Millennia Vs).  The UV-Vis spectrophotometer used to obtain spectra of MPO after laser 
exposure was made by Shimadzu (Model # UV-1650PC).  Both the laser and UV-Vis 
spectrometer used in these experiments are in the Martin Gruebele lab.    
 
Methods.  Yan observed changes in MPO surface spectra over a 3-4 hour period.  In order to 
investigate the potential changes in MPO on this time scale, independent of the liquid/gas 
free surface, and to detect plausible photoproducts that may arise to complicate the chemistry 
when using lasers for MPO kinetic studies, MPO was exposed to the laser described above 
for 30 minute intervals, after which any changes in the spectra of MPO were sought using 
UV-Vis spectroscopy.  Before beginning, 0.43 mL of phosphate buffer was added to the 
micro volume cuvette and a spectrum was obtained using the UV-Vis to determine the I0 for 
the buffer.  0.075 mL of 35 µM MPO was then added to the buffer in the cuvette, bringing 
the final concentration to 5.2 µM MPO and the total volume to 0.50 mL in the cuvette.  A 
spectrum of unexposed MPO over the entire range of the spectrophotometer (200 - 850 nm) 
was then obtained.   
 
The setup was simple (Figure 4.1).  A sample holder was used to hold the cuvette containing 
MPO in place while being exposed to the laser beam.  The cuvette holder was held at a 
constant temperature by flowing water through the holder from a temperature bath set at 
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27˚C.  The sample was exposed to the laser for 30 minutes at a time, then removed to obtain 
a spectrum.  A blank spectrum of phosphate buffer was taken before each MPO spectrum 
was obtained.  The MPO samples were out of the temperature-controlled environment for 
approximately 10 min for each spectral scan.  The experiment was carried out for a little over 
2.5 h, providing for 6 absorbance spectra of MPO to be obtained for comparison.  MPO 
sample was capped and inverted several times in order to mix the sample before each 
spectrum was taken and before placing it back into the path of the laser.  A control 
experiment was also conducted where a 5 µM MPO sample was held at constant temperature, 
following the same time intervals for analysis, but with no exposure of the sample to lasers. 
 
The SFG work conducted at Yale by Yan observed a 4 µg/mL solution of MPO prepared in 
phosphate buffer (0.1 M, pH 7).  The experiments were carried out in a Teflon beaker.  Sub-
picosecond pulses from a regeneratively-amplified Ti:sapphire laser (80 mW average power 
at 800 nm) and broadband infrared radiation as light sources were used to obtain vibrational 
spectra at the air/liquid interface.  Any spectral change was expected to indicate MPO 
structural changes over time.  Spectra were acquired every 5 m over a span of 5.5 h.  Surface 
tension was also measured (without laser exposure) to determine if the protein at the 
gas/liquid interface was restructuring on this time scale. 
 
4.3 Results and Discussion 
 
Surface tension and SFG measurements.  Results of the surface tension measurements 
showed that surface tension of MPO increased smoothly by 2.5-3 millinewton m-1 over a 3 h 
period following introduction of a freshly diluted solution to their apparatus.  It was not until 
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the stabilization of surface tension after 3 h that a peak at 1653 cm-1, which corresponds to an 
amide I vibrational transition, appeared.  There are at least two possible explanations for 
these results.  One is that even at a nominally motionless interface, an organized monolayer 
of protein will slowly form.  This time scale is promising because it suggests that over the 
tens of minutes that we plan for reactions in drops, there is a low probability of any molecule 
spending significant time at the interface, making the likelihood of denaturation at the surface 
even lower.  Due to MPO’s solubility, circulation in the drop should prevent protein island 
formation at the interface.  The other possibility is that no MPO is detectable at the 
solution/air interface for the first three hours because little is there.  This is plausible because 
MPO is so highly charged (isoelectric pH ≥10).  If this is true, MPO may be a nearly-ideal 
enzyme for study in levitated drops.  How then, would a hydrophobic form of MPO migrate 
to the surface?  A possibility is photochemical degradation by the laser.  It was this 
possibility I sought to examine. 
 
MPO stability at the surface/Laser exposure.  One of the questions that the SFG experiment 
results raised was; ‘What is causing the appearance of amide vibrations after several hours?’  
A hypothesis was that since absorbance at 800 nm at low fluence is negligible, perhaps 
multiphoton absorption (to vibrationally-excited components of the heme Soret band, ~400 
nm) leads to photo-oxidation and hydrophobic degradation products of MPO.  As a result, it 
might take several hours for the protein at the interface to form a sufficiently organized 
monolayer.  The laser exposure experiments conducted were to test the surface organization 
argument.   
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Figures 4.2 to 4.4 are the UV-visible light absorbance spectra for MPO exposed to laser light 
(Figures 4.2A and 4.4) and MPO solution that was not exposed (Figures 4.2B and 4.3).  
Comparing the spectra in Figure 4.2 A and B, there are visible differences in the absorbance 
intensity between the laser exposed and non-exposed MPO.  In Figure 4.2 A (non-exposed 
MPO), as the time increases. the absorbance intensity of MPO across the spectral range 
decreases by a similar increment for each time interval.  The same cannot be said for Figure 
4.2 B (laser-exposed MPO).  Compared to the initial spectrum of MPO (t=0 min, red line), 
the spectrum at t = 30 min (yellow line) actually increases in intensity by about 5%, and then 
decreases similarity to the non-exposed MPO.  This phenomenon could probably be 
explained by the temperature change experienced with solution as a result of initial exposure 
to the laser.  Heme spectroscopic signatures are particularly useful in characterizing the 
impact of the protein environment on the heme moiety and the perturbation by chemical or 
temperature stress.7  In this case, stability of the protein was monitored via absorption at 428 
nm (Soret band).  Both solutions were prepared using the same phosphate buffer, therefore 
the laser is the only variable that was different.   
 
In Figures 4.3 (no laser exposure) and 4.4 (laser exposure), I have taken the plots shown in 
Figure 4.2, normalized at 430 nm, then zoomed in on the X-axis, to get a better view of the 
possible changes taking place within the spectra.  Figure 4.3 shows spectra just incubated at 
27 ˚C in phosphate buffer for 2.5 h with spectra taken approximately every 30 minutes.  In 
Inset B, which is in the UV range of the spectrum (250-310 nm), the trend is reversed from 
that seen at 428 nm.  Instead of the absorbance intensity decreasing at the same rate of 
change from the lowest time to the highest, here the absorbance intensity at t=155 min has 
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the highest intensity and t=0 min has the lowest intensity (which it shared with t=30 min).  
Figure 4.4 B follows the same trend as 4.3 B except there is a clear distinction between the 
absorbance intensities of t=0 min and t =30 min.  In inset C for both Figures 4.3 and 4.4 there 
is something occurring between the 300-340 nm.  In Figure 4.3 C, MPO at t=0 min has a step 
increase at 325 nm that has completely disappeared for all the other time intervals.  Yet in 
Figure 4.4 C an absorbance increase is observed at each time interval.  This may be explained 
by the shifts and intensity increases observed in 4.3 D and 4.4 D, respectively.   
 
Inset D for both Figures 4.3 and 4.4 (390-470 nm range), include the 428 nm Soret band for 
MPO.  Because this wavelength was used to normalize the entire UV-vis spectrum, not many 
changes can be seen without zooming in.  For practical purposes, there is little net change in 
this region of the spectrum.  In Figure 4.3 D a similar trend to what is observed in Figure 4.6 
is seen.  As MPO is incubated in the buffer, there is a slight shift in the 428 nm peak to lower 
wavelength.  Although the change is small, it is there.  So while the absorbance of the spectra 
in Figure 4.4 D increases in magnitude as a result of the laser exposure and possible changes 
in temperature from t=0 min, the spectra in Figure 4.3 D remain at a constant intensity and 
instead the 428 nm peak shifts to shorter wavelengths the longer the solution is incubated.  In 
both cases, there is evidence that, over time, that some denaturation of protein is taking place.  
Based on results from a study conducted 1988 by Svensson, there is a possibility that the 
slight increases in intensity observed at 428 nm for the laser exposed MPO solution could be 
the induction of MPO complex II.  There is also the possibility that due to the lack of metal 
ions in the buffer, such as Ca2+, protein dissociation is occurring.  As seen in Figure 4.8, 
circled in orange are several of the calcium ions found in the MPO crystal structure.  If that 
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calcium were to dissociate, protein unfolding is highly likely.  This could change the 
conformational arrangement of MPO and affect its activity and spectrum.  Conducting a 
similar study to the ones described here, but adding metal ions to the phosphate buffer, would 
provide further insight as to whether or not this would positively or negatively impact MPO 
in solution.  
 
Inset E of both Figures 4.3 and Figure 4.4 reveal that not much activity is occurring at 570 
nm.  The total change in intensity is less than a 0.01 absorbance unit range.  The reason for 
looking closely at this particular wavelength is to determine if there are photoproducts of 
MPO that developed over time with exposure to laser light.  Insets Figures 4.3 and 4.4 E 
offer no suggestion that photoproducts of MPO are being generated.  The characteristic peaks 
of MPO are still present at 570 nm, and there are no shifts or major increases in absorbance 
that would suggest any products of MPO interactions are being formed.  
 
Figure 4.7 offers a look at the trends of absorbance over time at the characteristic 
wavelengths of MPO (428 nm, 570 nm, and 800 nm).  For both the laser-exposed and the 
non-exposed MPO, the absorbance trends remain consistent; as time increases, the 
absorbance of MPO decreases.  There is a slight increase in the ratio of absorbance at 570 to 
430.  The striking trends in absorbance changes at 280 nm and 320 nm could be correlated 
with a number of things.   Possible causes for the changes in the UV and deep UV could be a 
result of tryptophan and tryrosine or even cysteine sites being oxidized.  There is also the 
possibility of localized heating of the laser exposed MPO solution.  Another possibility is 
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oxidation by dissolved oxygen, perhaps involving radical chain reactions.  All of these are 
possible, but without further investigation and the generation of more spectra to test 
reproducibility, all of these hypotheses are unproved.  This experiment will need to be redone 
to test time and concentration dependence of the changes observed.   
4.4 Conclusion 
The data above suggest that even at low concentrations and with minimal environmental 
disturbances, for the most part the MPO-typical heme to protein bonds will remain intact and 
enable (nonspecific) heme coordination with the protein.  This is in strong contrast to heme 
peroxidases with noncovalently linked heme which lose their prosthetic group with the 
consequence of a significant blue shift of the Soret maximum to ~365 nm.  The short time 
period needed to study MPO reaction kinetics (tens of minutes), the fact that there is not a 
great concern for conformational changes, oxidation, denaturation or surface 
organization/restructuring of the protein at the interface, makes MPO promising as a protein 
to study in the LDR.  There is room for additional experiments to be conducted to be certain 
that this holds true under a wider set of conditions.  As mentioned above, it would be useful 
to repeat the experiment, varying the amount of Ca2+ in solution to see if it prevents MPO 
from unfolding.  Although this research did show that there was some type of chemical 
changes occurring within the MPO solution, a concern that of instability of the enzyme at the 
gas/liquid interface would be a dominant source of denaturation has been shown to be 
unlikely.  This is a step towards validating experiments on MPO in the LDR. 
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Figure 4.1 Setup for investigating the effects of direct laser exposure of 
MPO at the liquid interface.  
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Figure 4.2  Absorbance spectra of MPO (5 µM in phosphate buffer)over 
the entire UV-Vis spectral range; 200-850 nm. A) No laser exposure B) 
Laser exposure using a Ti-Sapphire 800 nm, 500 mW laser.  A spectrum of 
MPO was obtained every thirty minutes for experiments lasting 2.5 hours.  
Temperature was held at 27˚C in both cases. Both insets are the original 
spectra, zoomed in on the Y-axis to see the activity between 250-500  nm. 
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Figure 4.3  Control. No laser Exposure. Absorbance spectra of MPO 
that was exposed to laser light.  A) Across the entire spectral range of the 
UV-vis spectrophotometer, 200-850 nm, normalized at 430 nm.  B-E 
boxed in red in A are sections of the spectra that were blown up to 
analyze the activity at those particular wavelengths. B) 250-310 nm C) 
300-400 nm D) 390-470 nm and E) 540-610 nm.  Digitization 
granularity can be seen in inset E.   
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Figure 4.4  Laser Exposed MPO. Absorbance spectra of MPO that was 
exposed to laser light.  A) Across the entire spectral range of the UV-vis 
spectrophotometer, 200-850 nm, normalized at 430 nm.  B-E boxed in red in 
A are sections of the spectra that were blown up to analyze the activity at 
those particular wavelengths. B) 250-310 nm C) 300-400 nm D) 390-470 nm 
and E) 540-610 nm.  Digitization granularity can be seen in inset E.   
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Figure 4.5 The induction of MPO complex II by buffer. MPO (56 nM) was added to 50 
mM-potassium phosphate buffer, pH 7.0 (with supplements and substitution as indicated 
below), and the visible-light-absorption spectrum were scanned after 30 s (solid line). The 
MPO3+ spectrum (dotted line) is included as reference (see e). (a) No supplement; (b) 
freshly deionized water with resistivity 16 ΜΩ⋅cm (Milli-Q; Millipore Corp., Bedford, 
MA) substituted for the buffer; (e)+ 16 µg of catalase/ml + 200 µM-DTPA. These typical 
results were obtained by Svensson, B.E. Biochemical Journal, 256, “Conformational and 
Thermal Stability of Mature Dimeric Human Myeloperoxidase and a Recombinant 
Monomeric form from CHO Cells,” 751, 1988. This figure has been altered (utilized only 
insets a, b and e) and reproduced with permission of Elsevier Publishing. 
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Figure 4.6 Denaturation of mature MPO by GdnHCl as monitored by UV-
Vis spectroscopy.  A) Comparison of UV-vis spectra of 1.35 µM native ferric  
myeloperoxidase in 5mM phosphate buffer, pH 7 (gray line) and 1.35 µM 
myeloperoxidase incubated for 18hr in 6.0 M GdnHCl (black line).  These 
results were obtained by by Svensson, B.E. Biochemical Journal, 256, 
“Conformational and Thermal Stability of Mature Dimeric Human 
Myeloperoxidase and a Recombinant Monomeric form from CHO Cells,” 751, 
1988. This figure has been altered (utilized only inset a) and reproduced with 
permission of Elsevier publishing. 
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Figure 4.7  Absorbance of MPO at five different wavelengths  at 
various time intervals as a result of A) exposure to a Ti-Sapphire, 500 
mW, 800 nm picosecond pulsed laser and B) no laser exposure.  Each 
experiment was held at a constant temperature of 27˚C. 
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Figure 4.8  Cyrogenic crystal structure of human MPO 
isoform c. Obtained from the Protein Data Bank.  The green 
dots circled in orange represent several calcium ions that may 
be associated with maintaining tertiary protein structure.     
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CHAPTER 5  
 
CONCLUSIONS AND RECOMMENDATIONS FOR LDR 
DEVELOPMENTS AND APPLICATIONS 
 
 
Chapters 3 and 4 discussed the development of an acoustically levitated drop reactor system 
for use in to studying chemical kinetics in a single, microliter-sized drop.  Over the course of 
this research the levitation system has evolved from an idea and several drawings into a 
system that is fully operational.  The past few years of research and development have really 
positioned the next generation of researchers to focus primarily on chemistry, running 
experiments in the LDR.  This chapter discusses recommended future directions as it applies 
to both enzyme kinetics experiments in the drop and LDR optimization.  
 
 
5.1 Acoustically Levitated Drop Reactor System Optimization 
 
The levitator system described in the previous chapters, used to conduct various experiments, 
works.  For what it was designed for, which was to study chemical kinetics in a single drop, 
minimizing wall interactions, the levitator gets the job done.  There are areas where further 
development or optimization would save the next generation of researchers hours of 
preparation work and minimize frustration.  The areas that need to be addressed are in 1) 
sample-handling, 2) environmental controls and 3) computer controls.  
 
Sample handling:  
The 3-capillary, pressure-driven sample handling system described in chapter three has been 
improved several times.  The major issues with using the fused silica capillaries in the LDR 
system are 1) they are fragile and break easily, 2) they clog often and 3) without 
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pretreatment, they are not hydrophobic, so our generated drops are attracted to the sides of 
the capillary instead of staying on the end where the best optical measurements are obtained. 
To minimize these issues, we have developed a process by which to prepare bundles and coat 
them (inside to reduce protein adsorption and outside to reduce the amount of drop wicking).  
Although not optimal, it works, and as a result the capillary system has been effective in 
showing the potential for use of a levitated microdrop as a reactor.  This is useful, but there is 
still the limitation of having ~ 20% of the drop in contact with the capillaries in a system that 
we are referring to as wall-less.  The dead volume between the inlet vials and the drop is 
close to 0.5 mL (100 times the volume needed to form one drop), and it takes hours to 
prepare the bundles and an entire day for coatings to cure.  To reduce difficulties and move in 
a more efficient direction of sample handling, for batch reactions, replacement of the 
capillaries with Drop on Demand (DOD) dispensing is desirable.   
 
Drop on Demand dispensing ejects droplets from a syringe tip or nozzle into a desired space 
(Figure 5.1).  Based on the nodal structure in the levitation cavity, there is a high probability 
that a small drop aimed towards the levitation cavity will tend to the node and levitate 
without requiring much precision in its initial velocity.  Having tested this theory several 
times, it is clear that although a precise initial velocity is not necessary, proper position of the 
drop dispenser at a specific distance from the levitation cavity is necessary.  Assuring the 
same positioning of the drop dispensers each time will also be required to achieve 
reproducibility.  Determining this position may take some time initially, but once achieved 
will not require further attention.  The time saved makes a good case for investing time into 
the drop dispensers.   
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In addition to the time saved, a 100% wall-less reaction chamber will be achieved.  By using 
multiple drop dispensers, multiple reactants can be mixed together when ejected into the 
levitation cavity one after another.  Convective mixing in the growing, spinning drop and the 
continued circulation in the drop driven by the no slip boundary condition between gas and 
liquid aids mixing, as does the violent shaking of the drop when a droplet impacts (Figure 
5.2).  
 
We currently own DOD dispensers from two manufacturers.  They both can eject drops 
down to picoliters in size.  The dispensers from MicroFab Technologies can be run using 
computer controls and the dispensers from NanoLiter LLC come with drive electronics that 
are activated by a foot pedal.  Each has the capability to be computer controlled, which 
would be the most efficient approach. 
 
To remove drops, a single capillary connected to a vacuum line and a collection vial could be 
used.  It is desired in the future to use the levitation system as a continuously stirred tank 
reactor (CSTR), I would suggest a using a stopped-flow system or syringe pump with flow 
monitor and control system.  Unlike the current system, these systems would help with 
accuracy and reproducibility in drop formation.  The inlet lines would need to be short, with 
small inner diameters, to reduce the dead volume.  
Environmental Controls  
While adsorption to a reaction vessel wall is not a concern in a levitated drop, evaporation 
and condensation are major concerns.1,2  These concerns are addressed by using a controlled 
environment in which humidity, temperature,  ambient pressure, and gas composition 
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surrounding the drop are regulated.  Currently there are minimal systems in place to control 
the aforementioned variables.  There is an environmental box surrounding the levitator which 
can be closed during experiments to shield from drafts, debris, and other interferences.  This 
environmental box can be enhanced with various sensors and systems to control humidity, 
temperature, composition, and pressure.  For example, flowing heated or cooled gases 
through the environmental box can regulate the temperature around the drop.  Humidity 
control will require controls to avoid high or low humidity levels from adversely affecting 
the levitated drop.  One way to accomplish this would be to saturate the feed gas stream at a 
low temperature, then reheating the gas to operating temperature before releasing it around 
the drop.   
 
Considering most of the reactions will involve enzymes, maintaining the pH of analytes will 
also be very important.  Using dye in the substrates to monitor pH visually is one was to 
approach pH monitoring.  This could be used in conjunction with the computer controlled 
DOD dispensers to add buffer to the drop in small amounts until the pH is once again at the 
desired level.  There are many ways that environmental controls can be approached and will 
need to be easily adjustable to suit varying reaction conditions.  Installation of environmental 
controls should be a high priority before moving forward with enzyme kinetic experiments.   
 
Computer Control 
Although there is a small levitation community, we pride ourselves on having developed the 
most power-efficient and completely computer-controlled levitator available.  Unfortunately, 
those same computer controls display their limitations all too often.  (See Appendix B: 
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Operating an LDR.)  We rely on computer controls to control power to the levitator and 
gather the necessary information (temperature, pressure, and relative humidity surrounding 
the levitation cavity) needed to determine the reflector height that matches cavity resonance 
to transducer resonance frequency.  It there is a failure in this process and the reflector height 
is miscalculated, then the distance between the resonating plate and the reflector is off, no 
nodes are created, and levitation is difficult to achieve.  In addition to having to get the 
reflector height correct, it is also imperative to get the drive voltage correct; too high and the 
drop will explode, too low and the drop will fall out of levitation.  Both the initial drive 
voltage and reflector plate height are determined during the initial computer controlled-
sequence, and if that system fails to deliver the correct values, they have to be adjusted 
manually.  
 
An effective feedback loop system needs to be implemented that is always monitoring the 
levitation cavity temperature, pressure, and humidity and utilizes that information to adjust 
both the reflector height and drive voltage for optimal levitation.  A system that hunts for 
resonances would also prove useful in immediate levitation.  Implementation of these 
systems will shave time off experiments that are currently spent just trying to levitate the 
initial drop. 
 
In addition to controlling the levitation using a computer, a computer-controlled sample 
handling system is also needed.  Once environmental controls are in place there will be a 
need for a 100% hands-free sample handling because the environmental box will be sealed.  
These types of computer controls that have quick calibration systems and multiple feedback 
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loops so they are always checking the status of the levitation system will make levitation fast, 
reliable, wall-less, robust, and aid in reproducibility. 
 
5.2 Understanding Dynamics of a Levitated Drop 
The most important piece of the levitated drop system is the drop.  What is taking place 
inside the drop is what we are most interested in.  It is our reaction vessel.  By understanding 
the way the drop behaves in the levitation cavity, we will learn how to utilize those behaviors 
and changes in behavior to our advantage.  Studying the drop dynamics is an experiment well 
worth exploring.   
 
While I was doing the NADH chemiluminescence experiments discussed in chapter 2, I 
observed some interesting trends in the output spectrum when the drop was behaving 
abnormally.  Figure 5.3 shows examples of time series obtained while collecting data for 
Chapter 3.  These are less-than-ideal time series, as were obtained in over 80% of 
experiments.  The questions that I ask are 1) what causes these different phenomena to occur, 
2) how do the phenomena affect the reactants in the drop and 3) how can I initiate this 
phenomenon to achieve a desired result within my reaction?   
 
5.3 LDR Applications 
As mentioned earlier, aside from a few developments that the LDR could use to make it run 
more efficiently, the levitator system is useful in its current condition.  The intended purpose 
for this instrument was to study free-radical enzyme-catalyzed reactions and this thesis 
showed that this is possible.  The experiments presented here demonstrated the potential for 
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this wall-less, micro-environment system to be used as a micro-reactor to study a variety of 
biochemical reaction kinetics.  In addition to showing the use of the LDR for various 
experiments, good next steps would be to examine the feasibility of utilizing the other 
detection systems with the LDR.    
 
Two experiments that I attempted over the past year that would be good places to extend 
once the environmental controls and sample handling issues are addressed would be  
1) examining the Peroxidase-Oxidase oscillatory reaction within a levitated drop3 and  
2) sensing hydrogen peroxide in studying the inhibition effects of tryptophan and its analogs 
on myeloperoxidase4.  Both of these experiments involve reaction mechanisms important to 
human immune response.  They also can both be done on the macro-scale and then compared 
to the results obtained on the microscale (in the LDR).  One experiment deals with 
Myeloperoxidase, which in Chapter 4 we demonstrated might be one of the best-suited 
enzymes for conducting reactions in the LDR.  This experiment would be a beginning to the 
desired MPO research.  These experiments, which both employ electrochemistry to monitor 
either oxygen of H2O2, will also provide insight on how well electrochemical sensing is 
achieved in the levitation cavity.   
 
Another experiment that I attempted was to investigate the effects of hydrogen peroxide 
H2O2, Cl-, and HOCl on MPO. The idea was to expose MPO to the aforementioned analytes 
and use various types of mass spectrometry to see if these interactions caused any structural 
changes to MPO.  The idea came from an assertion made recently by Winterbourn and 
coworkers, based on results of a study they conducted, that modeled oxidant production 
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within phagosomes.  They suggested that the oxidation of neutrophil proteins within 
phagosomes is likely to affect their function.5  The study showed that MPO, treated with 
HOCl, killed a variety of bacteria and that amino acids and peptides reacted with HOCl to 
form dichloroamine groups which were unstable, yet bactericidal. In this reaction, MPO 
utilizes H2O2, which is generated by NADPH oxidase found in the phagosomal membrane, to 
oxidize Cl- to generate toxic oxidants, in this case HOCl, to destroy foreign microorganisms 
found in the body.6  The hypothesis is that the changes in MPO, for example, formation of 
polypeptide fragments could result in those fragments acting as an antibiotic, instead of 
relying only on the oxidizing chemistry of HOCl.  Unfortunately, we were only able to try 
one type of top-down mass spectrometry approach and the changes observed were not 
enough to draw any definite conclusions.  To further explore this scenario would also be 
worth the time.  Not only would mass spectrometry be coupled with the LDR, but it would 
directly address a critical facet of the hypothesized reaction network of MPO.  
 
There is much to be learned from these preliminary studies that will aid in the future studies 
of MPO dynamics and its involvement in ridding the body of foreign invaders.  The MPO 
network may be complicated, but the idea is to utilize this wall-less, micro-reactor to unravel 
the mystery.  
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5.4 Conclusions 
One goal of the Scheeline research group is to understand the innate immune system, 
particularly to unravel how neutrophils kill.  Our key to determining this is by understanding 
the myeloperoxidase reaction network, considering it is arguably the most important enzyme 
involved in host defense.  By understanding this reaction network we will potentially be able 
to determine how MPO is directly involved in host defense, and also how MPO contributes 
to atherosclerosis and other pathogenesis.  In order to effectively study this system, we have 
developed a wall-less microreactor system.  The system utilized ultrasound to levitate 
microliter-sized drops that are used to conduct reactions using a three-capillary bundle 
sample handling system.  Over the past few years, development of this levitation system has 
taken place and proof of concept experiments have been conducted.  It is clear that with a 
few further developments of this system, it will be optimal for studying enzyme-catalyzed 
reactions.  This system will aid in unraveling the complex myeloperoxidase reaction network 
for use in aiding future drug development.   
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5.6 Chapter 5 Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 5.1  A) Drive waveform required to generate drops using Drop-on-Demand 
technology. B) Microfab droplet dispenser generating a continuous stream of drops.  
(+V: 15V, -V: 15V) 
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Figure 5.2  Left inset shows 5 µL drop prior to step perturbation of acoustic field.  Middle 
and right insets show two disruptions of the same drop.  Drop returns to original shape 
between (or following) perturbations.  Exposure is 7 ms (150 frames s-1).  Data obtained by 
undergraduate Oluwafemi Masha. 
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Figure 5.3  Drop Pathological Phenomena. A-F. Transients of Lactate 
Dehydrogenase Catalyzed Reduction of Pyruvate to Lactate in the LDR .  Drop 
breathing (A and C), bubble formation and dissipation (B and E) , and spinning (C 
and F) are all presented here.  Bubbles formed during drop generation; most have 
dissipated within 15 s of drop formation.  Reprinted from Analytical Chemistry, 81, 
Pierre, Z., Field, C. and Scheeline, A., “Sample Handling and Chemical Kinetics in 
an Acoustically Levitated Drop Microreactor,” 8496, 2009, with permission from 
ACS publications. 
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APPENDIX A 
 
PROCEDURES FOR PREPARING 3-CAPILLARY BUNDLES 
 
 
Materials: 
 
You will need the following materials to prepare a capillary bundle for use in the LDR: 
 
3 – 0.30 m, 151 µm ID, 665 µm OD flexible fused silica capillary tubing  
(TSP10665, PolyMicro Technologies, Phoenix, AZ) 
 
A 1.65 mm ID, 0.1 m long tube  
(metal or plastic, to hold the bundles together during assembly and in LDR  
 
2 – 1.50 m ID (0.06 in ID) O-rings 
 
Pyrolin® Polyimide Coating (2-817A, Supelco, Bellefonte, PA) 
 
Small-tip paint brush 
 
Any type of hot plate, ring stand and claw clamp 
 
Fine grain Emery polishing paper (AA2, 2/0, 3M, St. Paul, MN) 
 
A BIC lighter 
 
Isopropanol 
 
Kimwipes® (Delicate Task Wipers, Kimberly-Clark, Roswell, GA) 
 
30 mL beaker  
 
Pirhana Solution = 15 mL Sulfuric Acid (H2SO4) + 5 mL of Hydrogen Peroxide (H2O2)  
(Do not prepare until ready to use.  SCS has specific safety rules for Pirhana solution.  
Use cautiously.) 
 
Storage vial filled with 10 mL MilliQ water 
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Procedures: 
 
1) Take the 3 flexible fused silica capillaries and bundle together using the 0.1 m 
long tubing and o-rings. 
 
2) Assure that at one end the capillaries align as flush as possible.  
 
3) Using the small-tip paint brush, starting at ~ 2.5 cm from the aligned tip, apply 
polyimide coating to the capillaries so that they form a bundle (apply down 0.1 m 
of the capillaries).   
 
4) Heat the hot plate to high heat (between 4 and 5 heat setting), set up the ring 
stand, and attach the claw clamp.  Use claw clamp to hold the capillary bundle ~ 
0.5 in from the hot plate surface for 20 minutes. (This will cure the polyimide and 
secure the capillaries together). 
 
5) Remove capillaries from hotplate.  Allow to cool 5 minutes, and then using the 
polishing paper, file down the capillary bundle side that was aligned in step #2.  
By doing this, you assure that the capillaries are not only aligned but as flush and 
smooth as possible for fluids to flow through, and for drops to hang from the tip. 
 
6) Once the tip that has been smoothed, heat it using the lighter until the capillaries 
glow red.  After cooling, rinse with isopropanol.  Wipe off remaining burnt 
coating with a Kimwipe.  This is done to remove the outer coating from the 
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capillaries.  This will allow for good adhesion of the CYTOP coating to be 
applied just before use of the bundle in the LDR. 
 
7) Prepare the piranha solution (NOTE: Prepare in a glass container. Be sure to add 
H2O2 to the acid. It will bubble and the container will become HOT!!).  Then 
immerse the tip of the capillary bundle, up to where the coating has been 
removed, into the solution.  Let sit for 20 minutes.  This will clean any debris or 
silica that may have gotten caught up in the capillary outlet during polishing. 
 
8) Store the capillary bundle in water to keep hydrated until ready for use. 
 
 
 
 
 
 
 
Pictorial Representation: 
 
 
 
3 Flexible Fused Silica 
Capillaries 
O-rings 
Tubing 
3-Capillary Bundle 
with exposed tip 
Front              
View 
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APPENDIX B 
 
BASIC INSTRUCTIONS FOR OPERATING THE LEVITATED 
DROP REACTOR 
 
 
 
 
LDR Major Components 
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1. Turn on the computer. Open the ‘LDR Programs’ folder that can be found on the 
desktop.  Double-click on the LabView ‘LDRStart.vi’ to open it.  (This may take 
a few minutes) 
 
                                                  
 
 
 
2.  Turn ON all Hardware. (see above schematic as a reference) 
a. the Agilent function generator 
b. the 20 KHz ×10 amplifier 
c. the fluid injection control system (be sure that the control switch is set to 
‘Remote’) 
d. the argon valve (it is above the LDR; turn knob so that is parallel with the 
pipe) 
e. the video camera (double click on ‘AVT Smartview’ icon on Desktop, 
click on OHCILynx, Click on O: Stingray F033B (AVT), Camera screen 
will appear on desktop, Press play on camera to get see LDR cavity. 
 
3. Using the LabView LDRStart.vi, start the levitator by clicking the white arrow.  
This will open the other LabView Vis useful in operating the levitator. 
 
a. The Agilent function generator will set to 20.73 kHz and 4.5 Vpp 
b. The argon gas, used to push fluids through the injection system, valve will 
open and release gas at between 35 and 40 psi. 
c. The reflector will automatically adjust to a height based on the 
temperature, pressure, and relative humidity in the room. 
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d. The following useful LabView Vis will open on the computer desktop: 
i. Linear Actuator Control  
(used to display and adjust the reflector height.  This program is 
linked to the foot-petals so they can be used instead of clicking 
buttons in this VI.) 
 
 
 
ii. Pressure Flow Valve Control  
(controls the gas flow necessary for fluid injection and removal)   
 
         
4. Assure that the capillary bundle is removed from the acoustic field before 
attempting this step. Using a 5µL syringe, levitate a drop of water.  
  
If drop does not levitate on the first attempt, try the following (in this order): 
a. Increase the voltage on the function generator to 5.8Vpp (or to a voltage 
just lower than 6Vpp, just before you hear a piercing noise coming from 
the levitator.  If you hear the piercing sound, the voltage you chose is too 
high.)  
b. Using the foot pedals, adjust the height of the reflector: 
i. Up, if the drop is falling to the sides of the radiating plate 
ii. Down, if the drop levitates but is bouncing up and down, rapidly 
 
c. Reduce the voltage if the drop is spinning rapidly              
 
i. ii. 
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5. Once a drop is levitating, Record the variables from LDRStart.vi and the reflector 
height for future reference. 
 
6. Use the micro-manipulators to move the capillary bundle towards the levitated 
drop until the drop is drawn to the capillary tip. 
If the drop wicks to the side of the capillary bundle, 
a. Wipe the capillary clean with a Kimwipe 
b. Move the capillaries out of the acoustic field 
c. Repeat steps 4 through 6 
 
7. To inject fluid into the LDR, use the Pressure Flow Valve Control VI. (see 3.d.ii) 
a. Flush the capillaries with fluid samples before beginning experiments (a 
typical flush volume is 5µL) 
b. Before forming droplets, be sure to set the desired injection volumes for 
the each vial 
c. You can inject samples individually (using ‘Inject Capillary 1 or 2’ 
buttons) or select the ‘Form Drop’ button to have the specified drop 
volumes of each sample injected automatically. 
d. The ‘New Drop’ button is used to remove a current drop and then form a 
new drop as soon as the old drop is gone. 
e. Select ‘Remove Drop’ if you just want to remove a drop and stop there.  
 
8. From here proceed with desired sampling and analysis. 
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